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ABSTRACT 
Liyang Zhao: The Role of Macrophage GLUT1-Mediated Glucose Metabolism in 
Atherosclerosis  
(Under the direction of Liza Makowski) 
 
Macrophages play a key role in the pathogenesis of atherosclerosis. We recently created a 
novel murine model with GLUT1 specifically deleted from monocyte/macrophages. Preliminary 
results from our lab suggest that macrophages lacking GLUT1 reduce the pro-inflammatory 
response. We therefore hypothesized that macrophages with GLUT1 deletion will have reduced 
pro-inflammatory activation during atherogenesis, which will reduce formation of atherosclerosis 
in a mouse model lacking the LDL receptor (Ldlr-/-). We transplanted bone marrow from Glut1fl/fl 
or Glut1MΦ-/- mice into Ldlr-/- mice and fed mice a Western Diet (WD) for 12 weeks. Glut1MΦ-/- 
Ldlr-/- mice exhibited significantly less plasma total cholesterol and LDL cholesterol compared 
to Glut1fl/fl Ldlr-/- mice. Additionally, our results demonstrated that mice with macrophages 
lacking GLUT1 displayed more and larger necrotic cores in atherosclerotic lesions compared to 
floxed transplanted controls. These results suggest that macrophage glucose metabolism 
mediates systemic cholesterol metabolism, and atherogenesis. Importantly, the maintenance of 
atherosclerotic lesion stability may be regulated by macrophage glucose metabolism-dependent 
mechanisms.   
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CHAPTER I - BACKGROUND 
Introduction 
 
Atherosclerosis, affecting large and medium sized arteries, is the underlying cause of 
about 50% of all deaths in Westernized societies (Lusis, 2000).  Factors including obesity, 
smoking, hypertension, elevated serum cholesterol, triglycerides, and free fatty acids, as well as 
decreased insulin sensitivity, are associated with increased risk of atherosclerosis. To date, there 
are limited relevant options to treat atherosclerosis besides prevention; therefore, further research 
into biological mechanisms is necessary. 
Atherosclerosis is a chronic inflammatory disease characterized by four major steps 
including 1) initiation of endothelial activation and inflammation; 2) promotion of intimal 
lipoprotein deposition, retention, modification, and foam cell formation; 3) progression of 
complex plaques by plaque growth and enlargement of the necrotic core, fibrosis, thrombosis, 
and remodeling; and 4) precipitation of acute events (Hopkins, 2013).  
 Lesion development is initiated by deposition of cholesterol-rich and apolipoprotein B-
containing lipoproteins, particularly low-density lipoprotein (LDL) in the subendothelial space of 
blood vessels. Physical interaction between LDL and proteoglycans causes accumulated LDL to 
remain in the subendothelial space. Mouse experiments show that mice expressing the 
proteoglycan binding– defective LDL had greatly reduced atherogenesis and that this effect was 
indeed due to decreased interaction of the mutated LDL with arterial wall proteoglycans (Tabas, 
Williams, & Boren, 2007). LDL retained within the intima can be chemically modified including 
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oxidation, aggregation, enzymatic or non-enzymatic cleavage, and hydrolysis all of which trigger 
local maladaptive responses to modified LDL (Moore, Sheedy, & Fisher, 2013). Modified LDL 
is pro-inflammatory, which enables it to activate overlying endothelial cells to express cell 
adhesion molecules such as intercellular adhesion molecule (ICAM) and vascular cell adhesion 
protein (VCAM) and secrete chemokines. Monocytes, attracted by activated endothelial cells are 
slowed down through rolling and stopped by attachment to the endothelial cells followed by 
transmigration to the subendothelial space. Upon stimulation by macrophage colony-stimulating 
factor (M-CSF) and other differentiation factors, monocytes differentiate into macrophages 
(Moore & Tabas, 2011). Scavenger receptor-mediated engulfment of oxidized LDL (oxLDL) 
transforms infiltrated macrophages to cholesterol-laden foam cells. The combination of 
macrophages taking up oxLDL through scavenger receptors and a lack of negative feedback 
keeps this engulfing process going non-stop. Eventually, accumulated cholesterol esters confer 
the macrophage “foam cell” characteristics. When the intracellular cholesterol content exceeds 
the foam cell’s processing capacity, foam cells undergo apoptosis. High concentrations of 
cytokines such as TNFa, unesterified cholesterol or oxysterols , oxLDL, activation of the Fas 
death pathway by Fas ligand (32), and ER stress all promote apoptosis processes (Seimon & 
Tabas, 2009). Apoptotic cells are readily cleared by macrophages through phagocytosis in the 
early lesion, however with the progression of lesion; phagocytosis of dead cells by lesion 
macrophages substantially decreases. Non-cleared apoptotic cells succumb to secondary necrosis 
and release cellular material into the microenvironment to ultimately create the necrotic core, a 
hallmark of unstable atherosclerotic lesion. Lesions considered advanced by their histology may 
or may not narrow the arterial lumen; however such lesions may be clinically significant because 
complications may develop suddenly (Stary et al., 1995; Virmani, Burke, Farb, & Kolodgie, 
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2002). Stages of atherosclerosis are shown in Figure 1. Pathological studies suggest that the 
development of thrombus-mediated acute coronary events depend principally on the composition 
and vulnerability of a plaque rather than the severity of stenosis (Lusis, 2000). Macrophages play 
critical roles in promoting lesion progression through secreting pro-inflammatory cytokines, 
matrix degrading enzymes, and reactive oxygen species which all contribute to lesion structural 
disorganization. Eventually, under the stress of various detrimental factors, lesions become 
vulnerable, and hematoma-hemorrhage and thrombus ensue, often leading to lesion rupture, 
myocardial infarction, and death.  
Figure 1: Illustration of the different stages of atherosclerosis (Hess, Marx, & Lehrke Michael, 
2012)  
 4 
 
 Through investigating the underlying causative mechanisms promoting atherogenesis, we 
can find more effective prevention and treatment methods for atherosclerosis and clinical events. 
Atherosclerosis is a multi-factorial disease and macrophages play an unparalleled role in almost 
every stage of its pathogenesis. Therefore, studying macrophage biology has become a primary 
interest in the field. A body of evidence has demonstrated that macrophages, a critical 
component of the innate immune system, contribute to chronic inflammation-related pathology 
including obesity, insulin resistance, and atherosclerosis. Moreover, substrate metabolism is one 
of the mechanisms that affects the macrophage inflammatory response. Hence, the research 
presented herein examined the mechanistic links between macrophage substrate metabolism and 
the inflammatory response in atherogenesis. 
Risk factors of Atherosclerosis 
 
A large body of evidence has shown that dyslipidemia, hypertension, smoking, metabolic 
syndrome, diabetes, and other underling disease are atherosclerosis risk factors (Altman, 2003).  
1) Dyslipidemia 
Anichkov first demonstrated the role of cholesterol in the development of atherosclerosis in 
1913 but the validity of the lipid hypothesis did not become generally accepted until 1984 
(Steinberg, 2013). Evidence from animal studies, epidemiological studies, and clinical trials of 
cholesterol-lowering therapies all support that hypercholesterolemia is a salient risk factor for 
atherosclerosis (Fruchart, Nierman, Stroes, Kastelein, & Duriez, 2004). LDL is the major plasma 
cholesterol transporter and is the predominant atherogenic lipoprotein. Dietary cholesterol and 
cholesterol synthesized by the endogenous pathway both contribute to the total amount of 
cholesterol in the body. LDL is taken up by cells through LDL receptor-mediated endocytosis; 
the expression of LDL receptor is regulated by intracellular cholesterol concentrations. Low 
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intracellular cholesterol activates sterol regulatory element binding protein (SREBP) which then 
enters the nucleus to up-regulate LDL receptor and HMG-CoA reductase, and other enzymes in 
cholesterol regulation and de novo cholesterol synthesis pathway. Conversely, high intracellular 
cholesterol down-regulates LDL receptor and HMG-CoA reductase and subsequently reduces 
endogenous cholesterol production (Horton, Goldstein, & Brown, 2002). Uptake of plasma 
cholesterol through LDL receptor-mediated endocytosis not only reduces plasma cholesterol 
concentrations, but also signals cellular lipid synthesis machinery to stop synthesizing 
endogenous cholesterol. Therefore, any genetic variation or mutation affecting the process of 
receptor-mediated LDL endocytosis leads to elevated plasma LDL and hypercholesterolemia. 
Evidence indicates that high LDL promotes atherosclerosis at every stage of its pathological 
development. Discoveries of LDL receptor defects in familial hypercholesterolemia patients, 
along with clinical trials of statin drugs that decrease plasma LDL and reduce coronary morbidity 
and mortality,  proved that LDL cholesterol is an independent risk factor of coronary heart 
disease (Grundy, 2002). 
2)  Hypertension 
Hypertension is associated with increased risk of atherosclerosis and, importantly, it shares 
similar cellular and molecular mechanisms with atherosclerosis, particularly from the 
endothelium perspective. Endothelial dysfunction appears to be one of the initiators of 
pathogenesis for both diseases (Alexander, 1995). Removing endothelial cells facilitates 
atherosclerotic lesion development in animal models, indicating that functional endothelial cells 
protect animals from atherosclerosis. It has been demonstrated that endothelial cells overlying 
lesions are intact but morphologically altered. Hypertension plays a central role in promoting 
 6 
 
endothelial cell morphology changes.  Under chronic hypertensive conditions, smooth muscle 
cells (SMC) of blood vessels experience adaptive hypertrophy and proliferation, salient features 
of hypertension, which confer blood vessels greater contractility. Thickening of blood vessels by 
SMC hypertrophy increases the distance required for diffusion of oxygen from the lumen. This 
in turn results in incomplete oxidation and eventually increases free radical production, which 
oxidizes subendothelial-retained LDL to oxLDL. Importantly, hypertension is one of the leading 
causes of atherosclerotic renal disease in the US. Prehypertensive state is associated with 
increased presence of inflammatory markers linked to atherosclerosis and even mild 
hypertension serves as an important risk factor for progression of chronic kidney disease toward 
irreversible renal failure (Chade, Lerman, & Lerman, 2005).  The pathogenesis of hypertension, 
like atherosclerosis, is extremely complicated. More importantly, it can enhance atherosclerosis 
through various other processes and remains one of the most relevant independent risk factors of 
atherosclerosis (Alexander, 1995).  
3) Diabetes  
Patients with type 2 diabetes (T2D) have an increased risk of cardiovascular morbidity and 
mortality. T2D and atherosclerotic vascular disease have shared pathogenic pathways, in which 
insulin resistance and abdominal obesity play central roles (Wassink et al., 2008). Macrophages, 
as an important component of the innate immune system, have been discovered to be the 
common culprit for both the pathogenesis of abdominal obesity related and insulin resistance 
(Chawla, Nguyen, & Goh, 2011). In obesity-induced insulin resistance, macrophages polarize to 
pro-inflammatory phenotypes and secrete cytokines, including interleukin-1β (IL-1 β), tumor 
necrosis factor-α (TNF-α), interleulink-12 (IL-12), etc. Pro-inflammatory cytokines, notably 
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TNF-α, disrupt insulin signaling pathways by phosphorylating insulin receptor substrate 1 (IRS1) 
307 serine and result in insulin resistance and eventually T2D. Furthermore, insulin resistance 
and T2D lead to hypercholesterolemia through increased lipolysis and decreased lipid clearance. 
Through sharing the same pathogenesis and directly causing dyslipidemia, T2D accelerates 
atherosclerosis. 
4) Other risk factors 
Atherosclerosis is a multifactorial disease: both genetic and environmental factors promote 
its development. Recent studies have characterized monocytosis, which is defined as elevated 
monocyte numbers in the circulation, as another independent risk factor for coronary artery 
disease in humans (Randolph, 2014). Studies have shown that hypercholesterolemia is associated 
with monocytosis through promotion of hematopoietic cell proliferation, signaled by alteration of 
cholesterol levels on hematopoietic stem cells, in mice, pigs, and rabbits (Moore et al., 2013; 
Randolph, 2014). Moreover, recent compelling evidence has shown that ApoE is able to regulate 
monocyte pool size (Randolph, 2014), demonstrated by the fact that ApoE-/- mice show a 50% 
increase in monocyte numbers relative to wild type mice (Moore et al., 2013). Interestingly, in 
hypercholesterolemic mice, monocytosis is mainly derived from an increase in the more 
inflammatory LY6Chi subset (Moore et al., 2013).  
Mouse Models of Atherosclerosis 
 
Due to the inexpensive cost, easy genetic manipulation, and relative short time frame of 
atherosclerosis development, murine models have been extensively used in atherosclerosis 
research (Getz & Reardon, 2012). Despite being the most favored species for atherosclerosis 
investigation, differences exist between mice and humans regarding lipid metabolism, risk 
factors, and pathological processes of atherosclerosis. For example, unlike humans, HDL is the 
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major lipoprotein in mice, and subsets of HDL in mice differ from human. Both of these 
characteristics render mice resistant to atherogenesis (Getz & Reardon, 2012). Murine models 
including mutations of LDL receptors or ApoE that increase LDL cholesterol, have distinct 
features: 1) most mouse models do not develop unstable atherosclerotic plaques, whereas in 
humans, a vulnerable plaque is the leading cause for a clinical acute cardiovascular event; 2) 
mouse models do not form thick fibrous caps which are frequently seen in human chronic 
atherosclerotic plaques; 3) mouse models develop the majority of plaques in the aortic root, but 
rarely in coronary artery, unlike humans; 4) in the mouse peripheral blood, there are 
approximately 50% pro-inflammatory monocytes (LY6Chi) and 50% anti-inflammatory 
monocytes (LY6Clow) circulating; whereas in humans the ratio of pro-inflammatory to anti-
inflammatory monocytes is approximately 9:1 (Moore et al., 2013; Randolph, 2014). Although 
differences in the characteristics of atherosclerosis exist between men and mice, murine models 
undeniably have contributed tremendously to our understanding of the mechanisms of 
atherogenesis (Getz & Reardon, 2012). Due to LDL receptor and ApoE’s critical functions in 
plasma lipoprotein levels, Apoe-/- and Ldlr-/- mouse models are two of the most frequently used 
mouse models for atherosclerosis research (Getz & Reardon, 2012).   
ApoE knockout mice were developed in 1992 by Dr. Maeda Nobuyo’s group at 
University of North Carolina at Chapel Hill, NC. ApoE serves as the ligand to mediate the 
uptake of chylomicrons, VLDL, and their remnants by hepatocyte LDL receptor and LDL 
receptor-related protein (Kolovou, Anagnostopoulou, Mikhailidis, & Cokkinos, 2008). Due to 
lack of ApoE in lipoprotein, Apoe-/- mice have reduced ability to clear plasma lipoprotein and 
therefore develop pronounced hypercholesterolemia, hypertriglyceridemia, and spontaneous 
atherosclerosis. Apoe-/- mice develop spontaneous fatty streaks in the proximal aorta at 3 months 
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of age and aortic sinus plaques at 8 months of age. When exposed to an atherogenic diet, Apoe-/- 
mice develop abundant and large aortic plaques after 14 weeks of diet exposure. ApoE is 
expressed in bone marrow-derived cells, mostly in the monocyte/macrophage lineage. Transfer 
of bone marrow cells from ApoE-/- mice into wild type mice increases aortic root atherogenesis 
independent of effects on plasma lipid concentration; therefore, macrophage-derived ApoE plays 
a large role in this model of atherosclerosis (Getz & Reardon, 2012).  
The Ldlr-/- mouse model was developed by Dr. Joachim Herz one year after the 
successful development of ApoE-/- mice. Previous studies have demonstrated that Ldlr−/− mice 
display moderate increases plasma lipids and develop no or only mild atherosclerosis when fed a 
regular chow diet. The Paigen diet (1.25% cholesterol, 7.5% cocoa butter, 7.5% casein, and 0.5% 
sodium cholate) and Western Diet (21% fat and 0.15% to 0.25% cholesterol) are the most widely 
used high-fat regimens to accelerate atherosclerosis in the Ldlr-/- mouse. When exposed to 
Western Diet (WD), Ldlr-/- mice show the presence of advanced lesions in the aortic sinus after 3 
months and in the innominate artery at 6 to 9 months on diet (Ma et al., 2012). Anatomy of aorta 
is shown in Figure 2.  
 
Figure 2:  Aorta anatomy (Di Luozzo, 2012). 
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Bone marrow transplant (BMT) serves as an extremely powerful tool for atherosclerosis 
studies. Transplanting bone marrow cells into atherogenic mouse models is useful in studying the 
roles of hematopoietic cells on atherosclerosis (Getz & Reardon, 2012). To accomplish BMT, 
atherogenic mice receive a lethal dose of irradiation prior to receiving bone marrow from either 
wild type mice or genetically modified mice. After reconstitution, chimeric atherogenic mice 
carry transplanted hematopoietic stem cells, allowing for the study of specific roles from newly 
transplanted blood cells. While BMT is a powerful tool to study the contribution of 
hematopoietic cells, some disadvantages include that irradiation in the recipient may not ablate 
100% of the hematopoietic system, irradiated mice do not gain as much weight on high fat diets 
(HFD) after irradiation, and, finally, irradiation can cause permanent damage to various tissues.  
Roles of Macrophages in Atherosclerosis 
 
Macrophages, central effectors of innate immunity, are recognized as key 
pathophysiologic agents in wide-spread disease processes associated with chronic inflammation 
and aging, including cancer, obesity-induced insulin resistance, and atherosclerosis (Moore & 
Tabas, 2011). Macrophages play a central role in the pathogenesis of atherosclerosis and 
investigating macrophage function has become a fundamental interest in understanding 
initiation, progression, and regression of atherosclerosis (Dickhout, Basseri, & Austin, 2008).  
The roles of macrophages in atherosclerosis are diverse, including: 1) being the 
precursors of foam cells; 2) secreting pro-inflammatory cytokines, chemokines, reactive oxygen 
species (ROS), reactive nitrogen species (RNS), matrix degrading enzyme, and anti-
inflammatory cytokines; 3) and contributing primarily to unstable plaque through imbalanced 
apoptosis and efferocytosis (Moore et al., 2013).  Macrophages sequester cholesterol within the 
atherosclerotic plaque and, more importantly, are implicated in critical events such as plaque 
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rupture (Randolph, 2014). During the initiation stage of atherosclerosis, through continual uptake 
of oxidized apolipoprotein B containing lipoproteins by scavenger receptor type A (SR-A) and 
CD36, macrophages clear sequestered lipoproteins in the subendothelial space. This is at first 
beneficial in restricting lesion expansion. However, there is little negative feedback following 
lipid uptake, and macrophages continually engulf lipoproteins and ultimately become 
cholesterol-laden foam cells (Moore et al., 2013). Unregulated lipid accumulation in 
macrophages results in increased secretion of pro-inflammatory cytokines, accelerated apoptosis 
and necrosis, defective phagocytic capacities, and reduced cell migration. All dysregulated 
macrophage functions lead to progression of atherosclerosis and finally cause “complex” 
atherosclerotic lesion formation. During the progression of atherosclerosis, macrophage 
inflammatory responses accelerate changes in lesion morphology, notably necrotic core 
formation and thinning of the fibrous cap, which are characteristic of the “vulnerable” lesions 
that most often lead to severe cardiac events and death (Moore & Tabas, 2011). Combined 
effects of increased macrophage apoptosis and defective macrophage clearance result in necrotic 
core formation. Besides pro-inflammatory cytokines, foam cells also secrete matrix 
metalloproteinases which degrade collagen, elastin, and proteoglycans in the extracellular 
matrix, thus promoting thinning of the fibrous cap. Macrophages orchestrate the aforementioned 
activities, highlighting their essential contributions to the underlying mechanism(s) for the 
progression and aggravation of atherosclerosis. There are many steps in the process by which 
macrophages contribute to atherogenesis.  
1) Monocyte recruitment: traffic into lesions  
Atherosclerotic lesions tend to be distributed at the inner curvatures and branch points of 
arteries. These are target sites for macrophage deposits due to increased endothelial cell 
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activation. Turbulent flow, hypertension, or other pro-atherogenic factors, such as oxLDL, 
activate endothelial cells. Upon activation, endothelial cells express chemokines that attract 
monocytes expressing cognate chemokine receptors. Activated endothelial cells subsequently 
express selectins and cell adhesion molecules, specifically ICAM and ACAM, which recognize 
respectively monocyte cell surface selectin ligands and cell adhesion molecules receptor 
integrins. Finally, firm adhesion of monocytes is followed by their entry into the subendothelial 
space (a process called diapedesis) (Moore & Tabas, 2011).  
Since the discovery of distinct subsets of monocytes in peripheral circulation systems by 
Geissmann in 2003 (Geissmann, Jung, & Littman, 2003), monocyte subsets have become an 
extensively investigated topic. In Both human and mouse monocytes fall into at least 2 
phenotypically distinct subsets: LY6Chi (which are also phenotypically Gr-1+CCR2+CX3CR1lo) 
and LY6CloW  (which are also phenotypically Gr-1–CCR2–CX3CR1hi) mouse monocytes 
correspond to human CD14hiCD16– and CD14+CD16+ monocytes (Swirski et al., 2007). In mice, 
hypercholesterolemia is associated with an increase in the pro-inflammatory LY6Chi monocyte 
subset which participates in the acute response to inflammation. LY6Clow monocytes are 
implicated in inflammation resolution. LY6Chi monocytes more readily enter atherosclerotic 
lesions than anti-inflammatory LY6Clow monocytes. LY6Clow cells express fewer integrin 
molecule LFA1 than LY6Chigh (Moore & Tabas, 2011; Moore et al., 2013). Importantly, in mice 
there are almost similar quantities of LY6Chi and LY6Clow monocytes in circulation; in contrast, 
95% of circulating monocytes in humans possess LY6Chi, which may account for why humans 
are more prone to develop atherosclerosis than mice.  
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2) Macrophage becomes foam cells:  
Modified LDL is able to activate endothelial cells, and endothelial activation in turn attracts 
more apoB-containing lipoproteins entering atherosclerotic lesion and retains them there. 
Accumulated LDL is modified by oxidation, acetylation, and aggregation. Upon arrival, 
macrophages starts engulfing modified LDL that are recognized by several macrophage pattern 
recognition receptor including SR-A1, CD36, SR-A2, CD68, SR-B1, and LOX-1. The majority 
of cholesterol in LDL exists in the form of cholesterol ester which, after internalization by the 
macrophage, is hydrolyzed to free cholesterol and fatty acids in late endo-lysosome, while free 
cholesterol undergoes re-esterification by ACAT to cholesterol ester. Cholesterol ester is stored 
in membrane-bound lipid droplets, therefore remains as a relatively inert form which confers 
foam cells “foam” characteristics (Moore et al., 2013). Unesterified or “free” cholesterol traffic 
from lysosomes to the plasma membrane and thus may become available for efflux out of the 
cell. However, free cholesterol has cytotoxic effects on cells, accumulation of which causes cell 
apoptosis or even necrosis (Moore & Tabas, 2011).  SR-A1 and CD36 are among the most 
studied macrophage scavenger receptors. In vivo experiments demonstrate that deleting either 
SR-A1 or CD36 significantly reduces atherosclerosis in ApoE-/- mice, clearly demonstrating that 
uptake of oxLDL by macrophages is critical in promoting atherogenesis (Boullier et al., 2001). 
Phospholipid constitutes the largest majority of lipid on the surface of LDL while neutral lipids 
are mainly located in lipid core. Evidence suggests that oxidized phospholipid is the most 
relevant component in mediating binding between scavenger receptors and oxLDL. 
Physiologically, macrophage scavenger receptors recognize apoptotic cells and bacteria, and 
eventually contribute to clearance of dead cells and infection, the process of which maintains 
homeostasis of organisms. It was speculated that oxLDL share similar surface modules, such as 
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oxidized phospholipids, with apoptotic and bacterial cell membranes and are therefore taken up 
as foreign bodies. Although the uptake of oxLDL by scavenger receptors could cause detrimental 
effects for cardiovascular systems, the role of scavenger receptors in innate immunity have 
persisted due to natural selection (Boullier et al., 2001). 
3) Foam cell inflammation 
Cholesterol uptake or accumulation drives macrophage activation through direct or indirect 
mechanisms. Directly, oxLDL acts as a ligand for pattern recognition receptors such as 
scavenger receptors and toll like receptors (TLRs). Depending on the extent of oxidation,  
oxLDL serves as agonist of either CD14-TLR4-MD2 or CD36-TLR4-TLR6 immune receptor 
complexes to activate a pro-inflammatory signal cascade which involves IL-1 receptor-
associated kinase 4 (IRAK4), myeloid differentiation primary-response protein 88 (MYD88), 
and NF- κB. Activation of NF-κB induces target gene expression including pro-inflammatory 
cytokines IL-1, IL-6, IL-12, IL-23, TNFα, and macrophage chemotactic protein-1 (MCP-1), 
which may all contribute to atherogenesis (Peled & Fisher, 2014). Furthermore, accumulated free 
cholesterol in cell membrane lipid rafts can activate TLR signaling pathway as well, which 
further magnifies NF-κB activation and targeted cytokine production. Cholesterol also induces 
the macrophage pro-inflammatory response indirectly by activating the NOD-like receptor 
family, pyrin domain containing 3 (NLRP3) Inflammasome pathway. Cholesterol crystals are 
present in early diet-induced atherosclerotic lesions and their appearance coincides with first 
appearance of inflammatory cells (Duewell et al., 2010). Both engulfed or de novo synthesized 
cholesterol crystals activate the NLRP3 Inflammasome which leads to the secretion of pro-
inflammatory cytokines IL-1β and IL-18 (Peled & Fisher, 2014).  
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Besides activating a pro-inflammation pathway, cholesterol loading in macrophages affects 
cells in various other aspects. Proteins involved with cytoskeletal regulation, vesicle-mediated 
transport, lipid binding, and apolipoprotein E are among the proteins most upregulated in 
peritoneal macrophages obtained from chow- vs. WD fed Ldlr−/− mice (Becker et al., 2010; 
Moore & Tabas, 2011). Boyle et al. demonstrated that TNFα secreted by macrophages together 
with Fas ligand (FasL) on macrophage cell membrane contributes to the vascular SMC apoptosis 
(Boyle, Weissberg, & Bennett, 2003). SMC is the only cell type that synthesizes extracellular 
collagens in an atherosclerotic lesion. Decreased collagen synthesis through impairing SMC 
function or reducing SMC numbers, and increased collagen degradation mediated by 
macrophage derived matrix metalloproteinases (MMP) result in thinning of the fibrous cap, 
which leads to “vulnerable lesion” formation. Alternatively activated macrophages (AAM) 
secrete TGFβ which is an important inducer for SMC collagen biosynthesis; however, TGFβ 
secretion is reduced in complex lesions, which substantially decreases SMC collagen synthesis 
and increases the vulnerability of these lesions (Moore & Tabas, 2011). 
4) Foam cell apoptosis and secondary necrosis 
Mechanisms promoting foam cell apoptosis include existence of extracellular oxLDL, 
accumulation of high concentrations of intracellular free cholesterol, production of pro-apoptotic 
cytokines such as TNF-α, excessive ROS production, growth factor withdrawal, hypoxia and 
direct cell–cell interactions such as binding of Fas-ligand to Fas (Schrijvers, De Meyer, Herman, 
& Martinet, 2007). Death of macrophages elicits complicated consequences regarding 
atherosclerosis outcome (Van Vre, Ait-Oufella, Tedgui, & Mallat, 2012).  In the early stages of 
atherosclerosis, apoptotic foam cells are effectively cleared by phagocytes, therefore increased 
foam cell apoptosis is beneficial in terms of inhibiting plaque progression. However, in the 
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absence of clearance, apoptotic cells rapidly expose phosphatidylserine on the surface, which is a 
potent activator in the generation of thrombin and activation of the coagulation cascade; 
simultaneously, apoptotic cells progress to secondary necrosis and autolyse, releasing potentially 
dangerous cellular components (Schrijvers et al., 2007).  With the progression of atherosclerosis, 
a majority of subendothelial macrophages become cholesterol-laden foam cells and gradually 
demonstrate less phagocytic capacity; hence, macrophage apoptotic cells and extracellular lipid 
accumulate in lesion plaques, form the necrotic core which is the hallmark of an unstable plaque 
and ultimately may lead to cardiovascular events through rupture of the lesion. 
5) Efferocytosis 
Macrophage apoptosis by itself will not trigger plaque necrosis. Rather, plaque necrosis 
results when apoptotic macrophages are not sufficiently cleared by phagocytes (efferocytosis) 
(Moore & Tabas, 2011). If apoptotic foam cells are not cleared efficiently by phagocytes, they 
eventually undergo a secondary necrosis process and subsequently release toxic intracellular 
contents including large amounts of tissue factors which trigger the coagulation cascade and 
thrombosis formation.  Therefore, effective removal of apoptotic cell debris prevents unstable 
plaque development, whereas, reduced phagocytosis of apoptotic cells increases vulnerability of 
the atherosclerotic plaque. Furthermore, efferocytosis activates phagocytes to express IL-10 and 
TGFβ which mount an anti-inflammatory response, and it promotes survival of the efferocytes 
themselves so that they do not succumb to potentially toxic factors in apoptotic cells (Moore & 
Tabas, 2011).  Professional phagocytes, such as macrophages and dendritic cells, rapidly 
recognize an apoptotic cell surface’s “eat me” signals, such as phosphatidylserine, and eventually 
phagocytize apoptotic cells (Schrijvers et al., 2007). Phagocytosis, which is the uptake of large 
particles (>0.5µm), involves active actin cytoskeleton rearrangement and remodeling. It is 
 17 
 
known that efferocytosis in atherosclerotic lesions is defective, however the underlying 
mechanisms are poorly studied. Venter et al. recently demonstrated that the capacity to undergo 
LPS-induced cell shape changes and to phagocytize particles does not depend on oxidative 
phosphorylation activity but is fueled by glycolysis. They postulated that in macrophages, 
glucose critically participates in non-metabolic regulation of actin cytoskeletal remodeling via 
posttranslational modification of receptors or signaling molecules (Venter et al., 2014). Other 
evidence suggests that effective phagocytosis requires macrophages to have intact lipid 
metabolism to maintain effective cholesterol esterification and efflux (Moore et al., 2013). 
Hence, while the role of metabolism in macrophage-mediated phagocytosis has been 
demonstrated, the exact substrates and metabolic pathways remain unclear. Illustration of the 
role of apoptosis and efferocytosis on atherosclerosis is shown in Figure 3. 
 
Figure 3. The role of efferocytosis and apoptosis on atherosclerosis (Van Vre et al., 2012). 
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6) Macrophage egress and lipid efflux 
It has been shown that macrophages can emigrate out of atherosclerotic lesions, and this 
phenomena happens more in the early stage of atherosclerosis. Moore et al. demonstrated that 
both cholesterol loading and hypoxia increase the expression of the neuro-immune guidance cues 
Netrin-1 and Semaphorin-3E which are encoded by gene Ntn-1 and Sema3e in mice , both of 
which function to induce macrophage chemostasis in vitro. Chimeric Ldlr-/- mice carrying 
deficient macrophage netrin1 display reduced atherosclerosis progression and increased 
macrophage emigration from lesions, suggesting that Netrin-1 may function to retain 
macrophages in plaques (Moore et al., 2013). Cells sense increased intracellular cholesterol 
content and decrease endogenous cholesterol synthesis and LDL receptor expression regulated 
by SREPB1, and increase expression of ATP binding cassette transporter A1 (ABCA1) and ATP 
binding cassette transporter G1 (ABCG1) through activation of LXR by cholesterol derivatives 
oxysterols and desmosterol. ABCA1 and ABCG1 are members of ATP-binding cassette 
superfamily participating in cholesterol efflux. Specifically, ABCA1 transfers cholesterol to 
lipid-poor APOA1 of HDL, and ABCG1 pumps cholesterol to mature HDL particles (Moore et 
al., 2013). This is a process called reverse cholesterol transport and understanding the role of 
macrophages in removal of cholesterol from plaques is vital. 
7) Macrophage polarization and inflammatory response  
In response to different metabolic and immune stimuli of the microenvironment, 
macrophages display a spectrum of phenotypes (Odegaard et al., 2007a). Relative to total 
numbers of macrophages, their subsets might be a better indicator of plaque phenotypes and 
stability. Based on cell surface expression markers, production of cytokines, and their biological 
function, macrophages are categorized into several classes (Chinetti-Gbaguidi, Colin, & Staels, 
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2015), notably classically activated macrophages (CAM), alternatively activated macrophages 
(AAM), and a spectrum of intermediate classes. Macrophages are activated by infection, 
cytokines such as IFNγ, or saturated fatty acids through classical activation pathway. Upon 
activation, CAMs secrete high concentrations of TNFα, IL-1β, IL-12, and IL-23, but low levels 
of IL-10 and TGFβ.  INFγ -/- /apoE-/-  double knock-out mice display significantly smaller 
atherosclerotic lesion than ApoE-/- mice, and exhibit a substantial increase in their collagen 
content, which indicate that loss of Th1 signaling polarizes macrophages to the less-
inflammatory state (Vats et al., 2006). From a functional point of view, CAMs participate in the 
removal of pathogens during infection through activation of the NADPH oxidase system and 
production of pro-inflammatory cytokines. In contrast, AAMs stimulated by type 2 T-helper 
cytokines IL-4 or IL-13 express IL10, IL-1 receptor antagonist, arginase-1, transforming growth 
factor; therefore, they are implicated in tissue remodeling and wound repair and categorized as 
anti-inflammatory. Functionally, AAMs can scavenge debris and apoptotic cells and promote 
plaque fibrosis (Chinetti-Gbaguidi et al., 2015; Johnson, Milner, & Makowski, 2012). In addition 
to the CAM and AAM subpopulations, other specific and distinct macrophage phenotypes exist 
in the heterogeneous and complex environment of the atherosclerotic plaque. Macrophages are 
extraordinarily plastic and can switch from one phenotype to another depending on the 
environmental cues (Chinetti-Gbaguidi et al., 2015). Due to their plasticity and apparent 
contrasting roles in innate immune systems, manipulation of macrophage populations can 
mitigate or exacerbate disease pathology (Johnson et al., 2012), for instance, in atherosclerosis, 
plaque composition influences the phenotype of macrophages, while macrophage subtypes in 
turn affect plaque structure and evolution resulting from their intrinsic activities (such as 
phagocytosis) and ability to release pro-inflammatory and anti-inflammatory factors (Chinetti-
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Gbaguidi et al., 2015). Thus, the composition of CAM to AAM ratios in the microenvironment 
of the vessel and plaque are very important. 
8) The Role of macrophage substrate metabolism in their inflammatory response 
Metabolism and immunity are two fundamental systems of metazoans. The presence of 
immune cells such as macrophage in metabolic tissues suggests a dynamic and on-going 
crosstalk between these two regulatory systems (Chawla et al., 2011).  In 2003, Xu et al. and 
Weisberg et al. demonstrated that macrophage infiltration caused elevated expression of pro-
inflammatory cytokines in adipose tissue of obese mice. TNFα, a cytokine largely produced by 
CAMs, promotes insulin resistance through phosphorylating serine 307 of insulin receptor 
substrate 1 (IRS1) - further demonstrating that macrophages play a critical role in metabolic 
disease (Chawla et al., 2011). Vats et al. demonstrated that in response to IL-4, signal transducer 
and activator of transcription 6 (STAT6) and PPARγ coactivator-1β (PGC-1β) induce 
macrophage metabolic programs for fatty acid oxidation and mitochondrial biogenesis. Increased 
glucose uptake and suppressed fatty acid uptake in CAMs, increased fatty acid uptake and 
elevated β-oxidation in AAMs indicated for the first time that there is a switch in nutrient 
utilization when macrophage shift from CAMs to AAMs (Vats et al., 2006). Etomoxir, 
mitochondrial inhibitor of fatty acid metabolism completely abolished macrophages’ anti-
inflammatory effects stimulated by IL-4. In contrast, inhibition of mitochondrial respiration did 
not have effect on inflammatory activation of macrophages stimulated by INFγ and 
lipopolysaccharide (LPS). Importantly, the aforementioned effects are independent of signal 
transducer and activator of Transcription 6 (STAT6) or peroxisome proliferator-activated 
receptor γ coactivator 1β (PGC-1β), suggesting direct involvement of mitochondrial oxidative 
metabolism in full expression of the anti-inflammatory AAM phenotype (Vats et al., 2006). 
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From a functional point of view, macrophage metabolic pathways that are either dependent upon 
glycolysis or oxidative phosphorylation, are critical for maintaining proper host defense. 
Glycolysis rapidly provides ATPs which are required by the respiratory burst to produce reactive 
oxygen species (ROS) and reactive nitrogen species (RNS) by CAMs to combat acute bacterial 
infection. In contrast, fatty acid oxidation provides a long-term energy supply which is needed by 
AAMs to secrete or express TGFβ, IL-10, and arginase I to fight intracellular parasite infections 
(Vats et al., 2006).   
Glucose Transporter 1 and its function on Macrophage 
 
Glucose transporter (GLUT) family and the sodium-dependent glucose transporter 
(SGLT) family are two classes of hexose transporters moving glucose into the cells. The GLUT 
family includes fourteen hexose transporters (twelve in mouse) which are facilitative transporters 
that transport sugars along the concentration gradient. The most widely expressed hexose 
transporter is GLUT1 which is thought to maintain basal glucose transport in most types of cells 
(Young et al., 2011).  Glucose is a critical component in the pro-inflammatory response of 
macrophages. Previous work from our group demonstrated that GLUT1 is the primary rate 
limiting glucose transporter on pro-inflammatory CAMs. Furthermore, in HFD-fed rodents, 
macrophages in crown-like structures and inflammatory loci in adipose and liver, respectively, 
stain positively for GLUT1. Freemerman et al. stably over-expressed the GLUT1 transporter in 
RAW264.7 macrophages (GLUT1-OE). Gene expression and proteome profiling analysis 
revealed that GLUT1-OE macrophages developed a hyper-inflammatory state characterized by 
elevated secretion of inflammatory mediators. Finally, ROS production and evidence of 
oxidative stress were significantly enhanced in GLUT1-OE macrophages. Importantly, inhibition 
of glycolysis using 2-deoxyglucose as well as antioxidant treatment blunted the expression of 
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inflammatory mediators such as PAI-1, suggesting that glucose-mediated metabolism and 
oxidative stress were driving the pro-inflammatory response in a GLUT1-dependent manner. 
These results indicated that increased utilization of glucose, induced a ROS-driven pro-
inflammatory phenotype in macrophages. Based on the in vitro overexpression data, the 
Makowski lab created a novel macrophage GLUT1-deficient mouse model to determine the 
contribution of GLUT1-mediated glucose metabolism to in vivo metabolic dysfunction. Recent 
work suggests that lack of GLUT1 reduced the pro-inflammatory response and the ability for 
GLUT1-/- macrophages to polarize to the classically activated state in vitro, which may play an 
integral role in the promotion of obesity-associated insulin resistance or atherogenesis.  
Rationale and Hypotheses 
 
Our previous work indicates that when macrophage fuel substrates are modulated in vitro 
simply by increasing uptake of glucose through overexpression of GLUT1 in RAW 264.7 cells, 
the response is dramatically driven toward pro-inflammatory or CAM-like phenotype. In order to 
investigate the effects of macrophage glucose metabolism in vivo, the Makowski lab created a 
novel mouse model wherein GLUT1 is specifically deleted in the monocyte/macrophage lineage 
through crossing a LysM-Cre mouse and Glut1fl/fl mice to generate Glut1MΦfl/fl or Glut1MΦ-/- mice. 
Studies demonstrated that abolishing glucose metabolism in bone marrow derived macrophages 
from Glut1MΦ-/- mice substantially decreased their capacity to mount a pro-inflammatory CAM 
response (manuscript in preparation). Interestingly, to test systemic effects of reduced glucose 
metabolism in macrophages in diet-induced obesity, mice were fed HFD or low fat diet from 
weaning and sacrificed at 24 weeks of age. There were slight but not significant increases in 
body weight in Glut1MΦ-/- compared to controls. In spite of the reduced inflammatory response in 
bone marrow derived macrophages (BMDMs), we observed more macrophage infiltration in 
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white adipose tissue from Glut1MΦ-/- mice compared to Glut1fl/fl controls. However, the 
macrophages in Glut1MΦ-/- were shifted towards AAM-polarized, not CAM-polarized as would 
be expected in obesity. Therefore, it appears that the lack of GLUT1-mediated glucose 
metabolism in macrophages blocked CAM-polarization and release of pro-inflammatory 
cytokines, even in an obese state.  
 The objective of this proposal is to ask if reduced macrophage glucose metabolism will 
also halt the formation of atherogenesis using the Ldlr-/- atherosclerosis mouse model. We 
hypothesize that macrophages with blunted glucose metabolism due to lack of GLUT1 will 
have limited inflammatory activation during atherogenesis and reduced plaque burden. In 
order to investigate the effect of deletion of macrophage GLUT1 on the pathogenesis of 
atherosclerosis, we transplanted bone marrow from Glut1fl/fl and Glut1MΦ-/- into the Ldlr-/- model. 
After 12 weeks WD feeding, we assessed atherosclerosis lesion formation status. The results are 
expressed in Chapter 2.  
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CHAPTER II - MANUSCRIPT  
Macrophages play a key role in the pathogenesis of atherosclerosis. Metabolic programs 
powered by glucose or lipids enable macrophages to elicit pro- or anti-inflammatory responses, 
respectively. Although the chronic inflammatory feature of atherosclerosis has been well-
established, the role of macrophage substrate metabolism in atherogenesis remains unclear. We 
previously demonstrated that macrophages with elevated GLUT1-mediated glucose metabolism 
have an increased inflammatory response. Therefore, we created a novel macrophage GLUT1-
deficient murine model by crossing floxed GLUT1 mice to LysM-Cre mice. Pilot studies suggest 
that lack of GLUT1 reduces the pro-inflammatory response and the ability for Glut1-/- 
macrophages to polarize to the classically activated state in vivo. Therefore, the objective of this 
study was to examine how macrophage metabolic reprogramming affects the development of 
atherosclerosis. We hypothesized that macrophages with restricted glucose metabolism due to 
lack of glucose transporter GLUT1 will have reduced pro-inflammatory activation during 
atherogenesis. We transplanted bone marrow from Glut1fl/fl or Glut1MΦ-/- mice into Ldlr-/- mice 
and fed mice a WD for 12 weeks. Glut1fl/fl Ldlr-/- or Glut1MΦ-/- Ldlr-/- chimeric mice did not 
exhibit significant differences in body weight, body composition, blood pressure, fasting blood 
glucose, or triacylglycerol and HDL cholesterol concentrations. However, Glut1MΦ-/- Ldlr-/- mice 
had significantly less plasma total cholesterol and LDL cholesterol compared to Glut1fl/fl Ldlr-/- 
mice. Digital histology analysis of Oil Red O (ORO) stained slides indicated that deletion of 
macrophage Glut1 did not affect total lesion area in aortic root; however, mice with blunted 
glucose metabolism displayed more and larger necrotic cores. In summary, we observed that 
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mice lacking macrophage GLUT1 had higher plasma cholesterol and developed increased 
necrotic cores in lesions of the aorta root relative to mice with wild type macrophage GLUT1, 
suggesting that macrophage glucose metabolism mediates systemic cholesterol metabolism; and, 
importantly, maintenance of atherosclerotic lesion stability may be regulated by macrophage-
specific glucose-dependent mechanisms.   
Introduction 
 
Atherosclerosis, a major cause of cardiovascular disease (CVD), is chronic inflammation 
that can proceed to acute clinical events by thrombosis and plaque rupture (Frostegard, 2013; 
Lusis, 2000). Atherosclerosis is tied to many risk factors including obesity, smoking, 
hypertension, elevated serum cholesterol, triglycerides, and free fatty acids, as well as decreased 
insulin sensitivity. Similar to obesity, one important driving force of atherogenesis is a 
microenvironment of chronic inflammation. Macrophage infiltration, partially due to 
overexpression of either MCP1 or its receptor CCL2, is implicated in local inflammation and 
insulin resistance (Odegaard et al., 2007a). There has been substantial progress in understanding 
the role of macrophages contributing to inflammation of vessels and adipose; however, the role 
of metabolism in regulating inflammation in atherosclerosis is poorly understood. Macrophages 
are involved in almost every stage of atherosclerosis, including but not limited to: 1) in the early 
stages: macrophages become foam cells through unabated engulfment of lipids, clearing 
neighboring dead cells, and secreting a spectrum of pro-inflammatory cytokines; 2) in the 
advanced stages: macrophages release matrix degrading enzymes, pro-coagulant tissue factors, 
and promote SMCs death.  The integration of inflammation and lipid signaling in macrophages 
contributes significantly to the pathogenesis of atherosclerosis, insulin resistance, and obesity 
through multiple pathways. These pathways include the nuclear hormone receptor peroxisome 
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proliferator activated receptor gamma (PPARγ), modulation of reverse cholesterol transport, the 
inflammatory Iκk-NFκB kinase pathway, and endoplasmic reticulum (ER) stress, as well as 
manipulation of macrophage glucose metabolism through deleting GLUT1 to alter the 
inflammatory response (Erbay et al., 2009; Makowski, Brittingham, Reynolds, Suttles, & 
Hotamisligil, 2005). 
Macrophages display tremendous heterogeneity regarding their functions and activities, 
reflecting their local metabolic and immune environment (Odegaard et al., 2007a). CAMs are 
pro-inflammatory and are formed through activation of the classical pathway when type 1 T-
helper (Th1) inflammatory cytokines IFNγ and TNFα are induced by cytokines, gram negative 
bacterial endotoxin (LPS), or saturated FA stimulation. In contrast, AAM are activated by type 2 
T-helper (Th2) cytokines IL-4 and IL-13 of the adaptive immune pathway. CAMs mount a 
robust inflammatory response combating infections, whereas AAMs are thought to be involved 
in remodeling and tissue repair through the production of IL-10, IL-1 receptor antagonist, and 
arginase-1 (Lumeng, Bodzin, & Saltiel, 2007). The skewing of AAM versus CAM levels in the 
vessel wall is as important as total number of infiltrating macrophages in the development of 
atherosclerosis (Chinetti-Gbaguidi & Staels, 2011; Leitinger & Schulman, 2013). Therefore, the 
purpose of this study is to address the gap regarding the knowledge of the mechanistic link 
between macrophage substrate metabolism and atherosclerosis development. Specifically, we 
focus on how macrophage glucose metabolism determines atherosclerotic plaque formation and 
morphology through affecting necrotic core and fibrous core formation.  
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Experimental Methods 
Reagents 
All reagents were purchased from Sigma-Aldrich (St. Louis, MO) unless otherwise noted. 
Carboxylate microspheres were obtained from Polysciences, Inc (Warrington, PA). Antibodies 
were purchased from the following sources: F4/80 (AbD Serotec/BioRad, CA); Annexin V PE 
Apoptosis Detection Kit PE (eBioscience, CA); Mouse IgG (Life technologies, CA); Goat anti-
Mouse IgG, Rhodamine Red conjugate (Life technologies, CA); Goat Anti-Mouse IgG Cy5 (Life 
technologies, CA); Alexa Fluor oxL488 Phalloidin (Life technologies, CA). DL and acetyl LDL 
were purchased from Alfa Aesar Company (Ward Hill, MA). Fluoro-Gel II with DAPI was 
purchased from Electron Microscopy Sciences (Hatfield, PA). Glucometer and Glucose strips 
were purchased from Abbott Diabetes Care (Abbott Park, IL). 
 Animals and Maintenance 
All animal experiments were performed in compliance with protocol approved by the 
University of North Carolina at Chapel Hill Institutional Animal Care and Use Committee. 
Glut1fl/fl mice were generously provided by Dr. Dale Abel (University of Iowa). LysM-Cre mice 
(stock number. 004781) and Ldlr-/- mice (stock number. 002207) were obtained from Jackson 
Laboratories (Bar Harbor, ME). Glut1fl/fl mice were backcrossed with C57BL/6J mice for 2 
(Erbay et al., 2009) generations in the University of North Carolina at Chapel Hill animal facility 
and then crossed with LysM-Cre mice. All mice were housed in a12-hour light-dark cycle with 
ad libitium access to food and water. To generate littermate Glut1fl/fl and Glut1MΦ-/- mice, male 
LysM-Cre+/+ and female Glut1fl/fl mice were bred and kept Glut1fl/fl/LysM-Cre+/- as breeders for 
experiments to generate littermates. Upon conducting BMT, chimeric Ldlr-/- mice were 
transferred to sterile cages with ad libitium access to sterile mouse chow and sterile water and 
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were maintained on chow diet for four weeks before challenge with WD (TD88137, 42% of Kcal 
from milk fat with 0.15% added cholesterol) from Harlan Teklad (Indianapolis, IN) for 12 
weeks.  
DNA isolation and GLUT1 genotyping 
DNA was isolated from mouse-tail tissues or BMDMs using a DNeasy Blood and Tissue 
Kit (Qiagen, Valencia, CA) and DNA concentration was measured by NanoDrop 2000 (Thermo 
scientific, DE). Genotyping was performed using the following primers: Flanked loxP forward – 
CTGTGAGTTCCTGAGACCCTG; Flanked loxP reverse – CCCAGGCAAGGAAGTAGTTC; 
FRT forward: TCCATTCTCCAAACTAGGAAC; FRT-R2: 
GAAGGCACATATGAAACAATG. iProof High-Fidelity PCR super mix (Bio-Rad, Hercules, 
CA)-based genotyping was performed on a C1000 thermocycler (Bio-Rad, Hercules, CA). 
Bone Marrow Transplantation 
Upon arrival, 32 4-week-old male Ldlr-/- mice were randomized to two experimental 
groups (n=16). Each group received bone morrow from Glut1fl/fl or Glut1MΦ-/- mice. At 6 weeks 
of age, recipient Ldlr-/- mice were administered two doses of X-ray irradiation (500cGy x 2, 
spaced 4 hours apart; X-RAD, North Branford, CT). Glut1fl/fl or Glut1MΦ-/- donor mice were 
anesthetized by Tribromoethanol (TBE, 0.02 ml/g of a 1.25% solution) and afterward sacrificed 
by cervical dislocation. After removing surrounding connective tissues, the femur and tibia were 
collected and bone marrow cells were flushed by ice-cold PBS containing 2% bovine calf serum 
(Hyclone, UT). Bone marrows were passed through cell strainers to remove large residue and 
cell suspensions were centrifuged at 1200rpm at 4°C for 5 minutes. After removing medium, cell 
pellets were resuspended in HBSS buffer (Life technologies, CA). Each recipient mouse received 
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5x106 bone marrow cells through retro-orbital injection under anesthesia. Control animals were 
transplanted with the HBSS buffer only and died within 10 days of lethal irradiation.  
Body weight and composition 
Body weight was measured prior to starting mice on diet and weekly until sacrifice.  
Body composition including lean mass, fat mass, free water content, and total water content of 
non-anesthetized mice was measured at age of 5, 10, 16, and 22 weeks old using the EchoMRI-
100 quantitative magnetic resonance whole body composition analyzer (Echo Medical Systems, 
Houston, TX). Fat mass or lean mass is presented as percent fat mass or lean mass over total 
body weight (Sundaram et al., 2013). 
Histology and immunohistochemistry 
Mice dissections were done as previously described but with minor modifications 
(Makowski et al., 2001a). Briefly, under the effects of anesthesia, left ventricles were perfused 
with PBS followed by 10% formalin and dissected out. Hearts with proximal aorta were fixed in 
10% formalin for 24 hours. 16 hearts were transferred to 70% ethanol and stored at 4°C for 
future creation of formalin fixed paraffin embedded (FFPE) sections and 16 hearts were 
transferred to 30% sterile sucrose for 72 hours. Serial interrupted sections from FFPE hearts 
were cut at 5µm thickness. Serial sections from frozen sections were cut at 10µm thickness. 
FFPE sections were stained with Masson’s trichrome for quantification of collagen content and 
necrotic cores. Frozen sections were stained with ORO and hematoxylin for quantification of 
lesion area.  
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Histology quantification  
Quantification of atherosclerotic lesions was done as described with modification 
(Bjorkbacka et al., 2004; Rotllan et al., 2015). Serial interrupted sections were cut through the 
aorta at the origins of the aortic valve leaflets, and every other section (10 µm) throughout the 
aortic sinus (1600 µm) was stained with ORO and hematoxylin.  Aortic lesion size of each 
animal was obtained by averaging 20 sections from the same mouse. 5µm serial interrupted 
sections were stained with Masson’s trichrome and used for quantification of collagen content 
and necrotic cores. A color deconvolution algorithm, developed by Bentley Midkiff from UNC 
Translational Pathology Laboratory, was used to separate collagen for digital quantification. 
Scores of collagen amount were given based on the product of algorithm calculated as optical 
density (OD) x percent of total positive area stained with collagen. Necrotic cores were 
quantified by Aperio ePathology software after manually circling necrotic area.  
Fasting Plasma Lipids 
After 6 hours of fasting, 200µl blood was collected into an ETDA coated tube by 
submandibular bleeding. Blood was centrifuged at 10,000g for 2 minutes at 4°C; plasma was 
then transferred to another tube. Plasma was diluted to 1:10 with PBS. From this diluted plasma, 
total cholesterol, HDL-cholesterol, and triglycerides were measured in the UNC Animal Clinical 
Chemistry and Gene Expression Core Facility by Vt350 automated chemical analyzer from 
Ortho-Clinical Diagnostics Company (Rochester, NY).  
Blood Pressure 
Blood pressure was measured as described previously (Zhou et al., 2012) with minor 
modifications using a tail-cuff system in UNC Rodent Advanced Surgical Models Core Lab. 
 31 
 
Mice (n=8) received 5 consecutive days of training on the tail-cuff blood pressure system 
(CODA, Kent Scientific, CA) prior to data collection. Starting on day 6, systolic and diastolic 
blood pressure was measured in conscious mice daily for 3 days. Mice were acclimated to the 
warm (32°C) restrainer for 15 minutes and blood pressure was recorded during 10 acclimation 
followed by 25 measurement cycles.   
Cell culture 
All cultures were maintained under a fully humidified atmosphere of 95% air and 5% 
CO2 at 37°C. Mouse thioglycollate-elicited macrophages were obtained as described (Makowski 
et al., 2001b; Zhang, Goncalves, & Mosser, 2008). 4% brewer thioglycollate was sterilized by 
autoclave and stored at -80°C for at least 3 months before use. On day 0, mice were injected with 
1 ml of sterile 4% thioglycollate in the peritoneal cavity. The sterile-inflammatory response was 
then allowed to proceed for 4 days. On day 4, mice were euthanized using a carbon dioxide 
chamber followed by cervical dislocation. Before making a small incision, the abdominal area of 
each mouse was cleaned with 70% ethanol. Then, 5ml of cold sterile PBS was injected into the 
peritoneal cavity, taking care not to puncture internal organs. The PBS was gently spread into the 
whole abdominal cavity and the same syringe was used to aspirate a cell suspension from the left 
side of the abdomen into a 50ml Falcon tube. The cell suspension was centrifuged at 1000rpm 
for 10 minutes at 4°C, followed by aspiration of the supernatant and lysis of red blood cells by 
ACK lysing buffer (Lonza, MD). The AKC buffer was neutralized by adding 13ml of RPMI cell 
media supplemented with 10% FBS, 1X L-glutamine, and 1X penicillin/streptomycin antibiotic 
mix (Corning, NY). Next, the cell suspension was again centrifuged at 1000rpm for 10 minutes 
at 4°C, the supernatant was aspirated, 3 ml of RPMI was added into the cell pellet, and the cells 
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were counted. Finally, the cells were diluted into different concentrations for plating 6-well and 
24-well plates. 
Phagocytosis assay 
Coverslips were coated in a 24-well plate with 1ml of 10µg/ml rat tail collagen I 
(Corning, NY) overnight in a sterile cell culture hood. Collagen-coated coverslips were then 
washed with sterile PBS twice and air dried. Mouse peritoneal macrophages were seeded at a 
concentration of 8x105 cells per well and left to attach to coverslips overnight. The carboxylated 
microspheres were opsonized with normal mouse IgG by mixing 3 ml of sterile PBS, 60µl of 
microspheres, and 60µl of mouse IgG and rotating this suspension at 37°C for one hour. 
Suspensions were centrifuged at 1600rpm for 10 minutes at 4°C, the supernatants were removed 
by aspiration, and the microspheres were resuspended in 3 ml of cold PBS and centrifuged at 
1600rpm for another 10 minutes at 4°C. After removing the supernatant, the microsphere pellet 
was resuspended in a final 200µl of cold PBS. 25µl of microsphere suspension was loaded into 
each well and after 20 minutes of incubation, phagocytosis was stopped by washing off non-
internalized microspheres with room temperature PBS three times for 10 minutes each time. 
Cells were fixed in 4% paraformaldehyde at room temperature for 10 minutes then washed with 
PBS three times for10 minutes. Cells were blocked by adding a blocking buffer of 1:1 ratio of 
10% BSA: 10% normal goat serum for 30 minutes. 250µl goat anti-Mouse rhodamine red-X 
1:750 in 1% BSA was added to each well for 15 minutes then cells were washed for 5 minutes 
three times by PBS. Cells were permeabilized in 0.1% Triton X-100 for 5 minutes and were 
washed 3 times by PBS, then blocked by the same blocking buffer for another 30 minutes.  Goat 
anti-Mouse Cy5 and Alexa 488-Phalloidin, both 1:500 in 1% BSA, were added to wells for 30 
minutes and then cells were washed twice for 5 minutes in PBS. Coverslips were gently removed 
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from wells and mounted to slides with Fluoro-Gel II with DAPI (Electron Microscopy Sciences, 
PA) mounting media for future analysis. ZEISS LSM 700 confocal microscope (UNC 
Microscopy service lab) was used to capture the images. Phagocytosis Index (PI) was calculated 
by numbers of microspheres took up by cells divided by total microspheres in the field. Results 
from 5 fields were averaged.  
Statistics 
For all in vivo and ex vivo data, statistical differences between experimental groups were 
determined by unpaired Student’s t-tests using statistical software within GraphPad Prism 
(GraphPad Software, Inc., La Jolla, CA). All data are shown as mean ± standard error of the mean 
(SEM). P values less than 0.05 were considered statistically significant.   
Results 
 
Deletion of macrophage GLUT1 did not alter metabolic parameters in Ldlr-/- mice 
Weekly body weight excluding 2 weeks after BMT and body composition including 
before BMT, before diet, and 6 weeks on diet and 12 weeks on diet were measured to determine 
if abolishing glucose metabolism in macrophages affects systemic metabolic parameters of Ldlr-
/- mice.  In addition, fasting blood glucose was measured every 3 weeks and fasting total 
cholesterol, HDL cholesterol, and triglyceride in plasma was measured at 12 weeks on WD. 
Glut1MΦ+/+ Ldlr-/-and Glut1MΦ-/- Ldlr-/- mice body weights did not differ after a 12 weeks WD 
exposure (Figure 5). Likewise, fat and lean muscle percentages were not significantly different 
between Glut1fl/fl Ldlr-/- and Glut1MΦ-/- Ldlr-/- mice (Figure 6 A-B). Interestingly, circulating total 
cholesterol and LDL cholesterol concentrations in plasma were significantly higher in Glut1MΦ-/- 
Ldlr-/- mice compared to Glut1fl/fl Ldlr-/- mice (Figure 7 A-B, p=0.0196 and p=0.0171). There 
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were no differences in plasma HDL cholesterol or triglycerides (Figure 8 A-B). Additionally, 
systolic and diastolic blood pressure was recorded at the age of 16 weeks of age, but there was 
no genotype effect (Figure 9 A-B). In addition, 6-hour fasting glucose was recorded at 5, 10, 13, 
16, 19, and 22 weeks of age with no GLUT1- mediated differences detected (Figure 10). 
Lack of macrophage GLUT1 does not affect atherosclerosis lesion size 
Preliminary data from the Makowski Lab indicated that Glut1MΦ-/- BMDMs failed to 
elicit a pro-inflammatory response. Glut1MΦ-/- expressed 80% less IL-1β and 60% less iNOS 
messenger RNA compared to Glut1fl/fl BMDMs. We sought to understand whether GLUT1-
mediated modulation of the macrophage inflammatory phenotype could reduce atherosclerotic 
plaque size since atherosclerosis is dependent on inflammation. To achieve our purpose, we 
conducted BMT by transplanting bone marrow collected from Glut1MΦ-/- or Glut1fl/fl mice or 
vehicle control HBSS buffer into Ldlr-/- mice through retro-orbital injection. After 12 weeks of 
WD exposure, we assessed aortic root lesion formation by histology. All mice that received 
vehicle transplantation died at 10 or 11 days post-irradiation, while all of the mice that received 
BMT survived. At the end point of the experiments, when mice were 22 weeks of age, we 
assessed lesion size by quantifying the average of lesion areas/section in both groups. After 
analyzing ORO stained aortic sinus lesions, we observed no difference in lesion size between 
Glut1fl/fl Ldlr-/- and Glut1MΦ-/- Ldlr-/- mice (Figure 11 A-C).  
Glut1MΦ-/- Ldlr-/- chimeric mice develop fewer and smaller necrotic cores than Glut1fl/fl Ldlr-/- 
mice 
Ldlr-/- mice develop advanced atherosclerotic lesions after a 12 weeks of high cholesterol 
diet (Subramanian, Thorp, & Tabas, 2015).  Advanced lesions are characterized by increased cell 
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death and necrotic core formation. We next sought to investigate whether abolishing glucose 
metabolism in macrophages affected the necrotic area. We analyzed Masson’s trichrome stained 
FFPE sections (Figure12 A-B) and observed more than a 50% increase in the necrotic area in the 
Glut1MΦ-/- Ldlr-/- mice compared to Glut1fl/fl Ldlr-/- mice (Figure 12 C). 87.5% (7 out of 8) of 
Glut1MΦ-/- Ldlr-/- mice developed necrosis but only 37.5% ( 3 out of 8) Glut1fl/fl Ldlr-/- mice 
developed a necrotic core (Figure 12 D). 
 Deletion of macrophage GLUT1 decreased collagen amount in aorta sinus 
Collagen is majorly secreted by lesion SMCs. MMP, secreted by pro-inflammatory 
macrophages and necrotic foam cells, degrades collagen and increases lesion vulnerability. 
Surprisingly, we observed a 20% decrease in collagen content in the aorta sinus of Glut1MΦ-/- 
Ldlr-/-  mice compared to Glut1fl/fl Ldlr-/-  mice (Figure 13 A-B, p=0.0161 and p=0.0065).  
Lack of GLUT1 decreased macrophage phagocytic capacity  
 Necrotic cores in atherosclerotic lesions largely result from an imbalance between 
decreased lesion efferocytosis and increased foam cell apoptosis.  Having observed a striking 
difference in the necrotic areas between Glut1fl/fl and Glut1MΦ-/- mice, we set out to test how 
deletion of GLUT1 affects macrophage phagocytic capacity in a phagocytosis assay using 
peritoneal macrophages isolated from Glut1fl/fl and Glut1MΦ-/- mice (Figure 14 A-B). 
Phagocytosis Index (PI) was 69.7% and 57.2% respectively in Glut1fl/fl and Glut1MΦ-/- 
macrophages (Figure 14 C, p=0.013). Glut1MΦ-/- macrophages had 16.3% reduction of their 
phagocytic capacity relative to GLUT1fl/fl macrophages.    
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Discussion 
 
A body of evidence has demonstrated that macrophages are implicated in chronic adipose 
tissue inflammation, obesity, insulin resistance, and T2D. Macrophage metabolism and the 
immune response are closely intertwined with each other (Odegaard & Chawla, 2011). The link 
between fatty acid oxidation and macrophage alternative activation has been elucidated 
(Odegaard et al., 2007b; Vats et al., 2006). However, the role of glucose metabolism in 
regulating macrophage polarization is still poorly understood. GLUT1 is the predominant 
glucose transporter on macrophages (Freemerman et al., 2014). In order to understand how 
glucose metabolism affects macrophage polarization, our lab created a mouse macrophage RAW 
246.7 cell line which stably over-expressed GLUT.  Freemerman et al. demonstrated that over-
expression of GLUT1 significantly increased glucose uptake, lactate production, and 
simultaneously TNF-α, IL-1β, IL-6, and PAI-1 gene expression, in a glycolysis and ROS-
dependent manner, indicating that glucose metabolism plays a key role in driving macrophage to 
mount a robust, pro-inflammatory response (Freemerman et al., 2014). We generated a novel 
Glut1MΦ-/- mouse model wherein Glut1 was specifically deleted from hematopoietic myeloid 
cells using LysM-Cre. Preliminary data demonstrated that lack of GLUT1 decreased iNos and 
IL-1β gene expression in BMDMs. In addition, Glut1MΦ-/- mice made obese by HFD displayed 
elevated macrophage infiltration and crown like structure formation in epididymal white adipose 
compared to Glut1fl/fl mice, yet a striking lack of inflammation was evident, despite greater 
macrophage infiltration. Macrophage in white adipose of Glut1MΦ-/- mice were polarized towards 
the AAM phenotype, despite being in a state of obesity with excessive macrophage infiltration 
(manuscript in preparation). Taken together, the data suggests that glucose is the primary fuel 
metabolized by pro-inflammatory macrophages (Freemerman et al., 2014). Since macrophages 
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play a central role in the pathogenesis of atherosclerosis, and because obesity and atherosclerosis 
share certain common etiologies such as chronic inflammation, we intended to expand our 
knowledge garnered from the in vitro GLUT1 gain of function model and the in vivo GLUT1 
loss of function obesity mouse model to investigate how macrophage glucose metabolism affects 
atherosclerosis. We chose to use atherogenic Ldlr-/- mice as bone marrow recipient mice because 
transplanting ApoE+/+ macrophages into ApoE-/- mice decelerates atherogenesis in ApoE-/- mice 
(Getz & Reardon, 2012). Our initial hypothesis was that mice with mutated macrophage glucose 
metabolism would develop reduced atherosclerosis because of decreased macrophage pro-
inflammatory response. However, after 12 weeks of WD exposure, deletion of macrophage 
GLUT1 surprisingly did not affect atherosclerotic lesion size per se but strikingly altered the 
composition of lesions compared to floxed controls. Lack of macrophage GLUT1 increased 
necrotic core formation and decreased aorta sinus collagen content.  
We showed that deletion of macrophage GLUT1 did not affect Ldlr-/- mouse body weight 
or fasting glucose. We also did not observe any difference on other systemic measurements 
including body composition, blood pressure, plasma HDL cholesterol, and plasma 
triacylglycerol. Of note, Glut1MΦ-/- Ldlr-/- mice fed 12 weeks of WD had significantly higher 
plasma total cholesterol and LDL cholesterol than Glut1fl/fl Ldlr-/- mice. Plasma cholesterol 
concentration is determined by endogenous cholesterol synthesis, dietary intake, and clearance. 
All mice received WD during the 12-week diet exposure; therefore it was likely that deletion of 
macrophage GLUT1 affected liver cholesterol synthesis or secretion. Our preliminary data 
indicated that Glut1MΦ-/- mice developed more crown like structure (CLS) than Glut1fl/fl mice in 
epididymal white adipose tissue when mice were made obese on a HFD. The elevated 
macrophage influx as measured by CLS, qPCR, and flow cytometry was likely due to increased 
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expression of MCP-1 in Glut1MΦ-/- adipose tissue; MCP-1 expression was 70-fold higher in 
Glut1MΦ-/-  epididymal white adipose compared to Glut1fl/fl adipose tissue. One explanation for 
increased plasma total cholesterol and LDL cholesterol is that deletion of macrophage GLUT1 
could have increased macrophage liver infiltration, and consequently increased total activity of 
pro-inflammatory cytokines such as IL-1β. It is well established that pro-inflammatory 
cytokines, including TNF-α, IL-1β, and IL-6, increase hepatic de novo cholesterol and 
lipogenesis (Popa, Netea, van Riel, van der Meer, & Stalenhoef, 2007; Zhao et al., 2011).  
Phagocytosis is the process of engulfing particles larger than 0.5µm and requires receptor 
participation. Macrophages play critical roles in defending against infection, maintaining tissue 
homeostasis, and remodeling through phagocytizing foreign bodies such as bacteria, fungi, and 
apoptotic bodies. Cells undergoing apoptosis release various molecules such as ATP, 
lysophosphatidylcholine, and sphingosine 1-phosphate which function as chemokines, recruiting 
phagocytes to the vicinity of dying cells (Flannagan, Jaumouille, & Grinstein, 2012). Venter et 
al. demonstrated that glycolysis fuels LPS-induced macrophage cell shape changes and 
phagocytosis of zymosan particles in the RAW macrophage 246.7 cell line, which highlights the 
role of glucose in maintaining functional macrophage phagocytosis (Venter et al., 2014). 
Unabatedly engulfment of oxLDL renders macrophages susceptible to apoptosis. If phagocytes 
are able to effectively clear the apoptotic bodies, the extent of secondary necrosis and necrotic 
cores would largely reduce, conversely decreased phagocytosis results in increased necrotic core 
formation. 6-Phosphofructo-2-kinase/fructose-2, 6-biphosphatase 3 (PFKFB3) regulates the rate-
limiting step of the glycolysis pathway. Nishizawa et al. showed that knocking down GLUT1 by 
siRNA decreased PFKFB3 gene expression (Nishizawa et al., 2014). Besides its important role 
in glycolysis, PFKFB3 also regulates actin cytoskeleton remodeling (De Bock et al., 2013). 
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Therefore we speculated that lack of GLUT1 decreased PFKFB3 activity which further reduced 
actin cytoskeleton remodeling in macrophages. Macrophages with reduced ability to rearrange 
actin cannot form proper pseudopodia, and therefore phagocytic capacity is impaired (Coppolino 
et al., 2002). In the subendothelium space of blood vessels, decreased macrophage phagocytic 
capacity eventually leads to necrotic core formation in atherosclerotic lesion.  
To characterize the effect of GLUT1 on phagocytic capacity, we performed an ex vivo 
phagocytosis assay to test the capacity of thioglycollate-elicited peritoneal macrophages to 
phagocytose normal mouse IgG opsonized 2µm microspheres as a model of engulfing 
Lipoproteins. Results of the pilot study suggested that Glut1MΦ-/- macrophages displayed reduced 
phagocytic capacity relative to Glut1fl/fl macrophages. These findings corroborated our findings 
on histologic quantification of necrotic cores. Furthermore, preliminary data in diet-induced 
obese mice suggested that although macrophages infiltrated in greater numbers in Glut1MΦ-/- 
mice, they failed to polarize to CAMs. One hypothesis is that the macrophages infiltrate but fail 
to activate because of a lack of phagocytic capacity of macrophages lacking GLUT1. We also 
observed decreased collagen content in Glut1MΦ-/- Ldlr-/- mice compared to Glut1fl/fl Ldlr-/- mice 
which may have resulted from increased MMP released by necrotic Glut1MΦ-/- foam cells. Taken 
together, we have provided preliminary data that macrophage GLUT1 is required to 
maintain the functional phagocytic capacity and therefore sustain atherosclerotic lesion 
stability.  
A recent study also examined macrophage GLUT1 by gain of function strategy. By 
transplanting Ldlr-/- mice with macrophages overexpressing GLUT1, Nishizawa et al. reported 
that increasing macrophage glucose metabolism by over-expressing GLUT1 did not affect 
atherosclerosis. They demonstrated that there was no difference in atherosclerosis lesion size and 
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necrotic areas between GLUT1 overexpressed macrophage and wild type macrophage 
transplanted Ldlr-/- mice (Nishizawa et al., 2014). This was the first article to document the role 
of macrophage glucose metabolism in atherosclerosis. Our results were consistent with their 
finding that altering macrophage glucose metabolism did not affect atherosclerotic lesion size, 
but by utilizing a loss of function model we observed that mice with deleted macrophage GLUT1 
developed more and larger necrotic core areas in atherosclerotic lesions. We speculate that 
overexpression of macrophage GLUT1 either maintains or increases PFKFB3 activity and 
as a result, decreased macrophage phagocytic capacity was not seen in Nishizawa’s study. 
   In summary, deletion of macrophage GLUT1 increased plasma total cholesterol and 
LDL cholesterol but did not affect body weight, body composition, or fasting glucose. In the 
aorta sinus, more and larger necrotic cores but less collagen content were observed in Glut1MΦ-/- 
mice. We hypothesize that deletion of macrophage GLUT1 may have increased liver lipogenesis 
and furthermore that maintenance of atherosclerotic lesion stability may be regulated by 
macrophage specific glucose-dependent mechanisms. In order to test our hypothesis we will 
measure total lipid content in liver from frozen liver tissues; also stain liver FFPE sections with 
macrophage surface marker F4/80 to examine liver macrophage infiltration. In future studies, we 
aim to repeat ex vivo phagocytosis assays and further measure whether deletion of GLUT1 
increases macrophage apoptosis. Last, we will stain aorta sinus sections with Mouse 
Macrophages/Monocytes antibody (Moma-2) to quantify aorta root macrophage infiltration. 
Taken together, this study provides evidence for the first time that macrophage GLUT1-
dependent glucose metabolism plays a critical role in maintaining atherosclerotic lesion stability. 
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Figure 4. Diagram of Study Design. Littermate male Glut1fl/fl and Glut1MΦ-/- donor mice were maintained at the UNC animal facility. 
Recipient male Ldlr-/- mice were purchased from Jackson laboratory at 4 weeks of age. At 6 weeks of age Ldlr-/- mice were lethally 
irradiated and transplanted with 5x106 bone marrow cells which were collected from sex- and age-matched donor mice. Chimeric Ldlr-
/- mice were reconstituted for 4 weeks before being exposed to WD for 12 weeks. At the age 22 weeks, mice were sacrificed.
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Figure 5. Deletion of macrophage GLUT1 did not increase Ldlr-/- mice’s susceptibility to 
weight gain.  Body weights of Ldlr-/- mice were measured weekly starting at 5 weeks of age. 
Irradiation and BMT occurred at 6 weeks of age (black arrow). WD started at 10 weeks of age 
(purple arrow). Blood pressure was measured at 16 weeks of age (red arrow)   (n=16 per Glut1 
genotype).   
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Figure 6. Deletion of macrophage GLUT1 did not alter body composition in recipient Ldl-/- 
mice. (A) Body fat mass and (B) lean mass percentage were measured by Echo MRI   at 5, 10, 16, 
and 22 weeks of age corresponding to before BMT, before diet, 6 weeks on diet, and 12 weeks on 
diet (at sacrifice). Data are presented as means ± SEM, n = 16 per Glut1 genotype. 
A 
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Figure 7. Lack of macrophage GLUT1 increased plasma total cholesterol and LDL 
cholesterol. Six hour fasted plasma lipids at 22 weeks of age were measured in the UNC Animal 
Clinical Chemistry and Gene Expression Core Facility. (A) Total cholesterol was 1464±77 mg/dl 
for Glut1MΦ-/-Ldlr-/- mice, and 1223 ± 59.07 mg/dl for the Glut1fl/fl Ldlr-/- mice. (*P<0.05).  (B) 
LDL cholesterol was calculated by subtracting HDL cholesterol from total cholesterol. LDL 
cholesterol were 1071 ± 62.62 mg/dl for the Glut1MΦ-/-Ldlr-/- mice, and 873.1 ± 46.93 mg/dl for 
the Glut1fl/fl Ldlr-/- mice. (*P<0.05).  Data are presented as means ± SEM, n = 16 per Glut1 
genotype. 
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Figure 8. Lack of macrophage GLUT1 did not alter plasma HDL cholesterol and 
triacylglycerol. (A) 6 hours fasted plasma HDL and (B) triacylglycerol were measured in UNC 
Animal Clinical Chemistry and Gene Expression Core Facility as above. Data are presented as 
means ± SEM, n = 16 per Glut1 genotype. 
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Figure 9. Deletion of macrophage GLUT1 did not change blood pressure after 6 weeks on 
WD. Blood pressure was measured at 16 weeks of age using a tail-cuff system. (A) Systolic and 
(B) diastolic blood pressure were measured in Glut1MΦ-/-Ldlr-/-and Glut1fl/fl Ldlr-/- mice. Data are 
presented as means ± SEM, n = 8 per Glut1 genotype. 
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Figure 10. Lack of macrophage GLUT1 did not change fasting plasma glucose.  6 hours fasted 
glucose was measured at indicated time points in Glut1MΦ-/-Ldlr-/-and Glut1fl/fl Ldlr-/- mice. Data 
are presented as means ± SEM, n = 16. 
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Figure 11. Deletion of macrophage GLUT1 did not affect atherosclerotic lesion size in the 
aorta sinus.  Serial interrupted 10µm sections were stained with ORO and counter stained with 
Hematoxylin. Slides were scanned by Aperio Digital Slides Scanner. (A-B) 20X representative 
photomicrographs of ORO staining. Black arrow indicates representative lesions quantified. (C) 
Quantitative analysis of atherosclerotic lesion size in Glut1fl/fl Ldlr−/−or Glut1MΦ-/-Ldlr−/− mice. 
Data are presented as means ± SEM, n = 8 per Glut1 genotype. 
     A   Glut1fl/fl Ldlr-/-                                                     B     Glut1MΦ-/- Ldlr-/-  
C 
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Figure 12. Increased necrotic core formation in Ldlr-/- mice reconstituted with Glut1MΦ-/- bone 
marrow. (A-B) 20X representative photomicrographs of Masson’s trichrome staining. Black 
arrow indicates representative necrotic core quantified. (C) Average necrotic area per section. Data 
are presented as means ± SEM, n=8. (D) Percent of Glut1fl/fl Ldlr−/−  versus Glut1MΦ-/- Ldlr−/− mice 
that developed necrotic core at sacrifice. n=8 per Glut1 genotype. 
C 
D 
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Figure 13. Lack of macrophage GLUT1 decreased collagen content in aorta sinus. Histologic 
analysis of collagen was performed using a color deconvolution algorithm in Aperio ScanScope 
software. Scores were assigned based on collagen content in regions of atherosclerotic lesions. (A) 
Collagen content score. (*P<0.05). (B) Calculated intensities of positive collagen staining 
(**P<0.01). Data are presented as means ± SEM, n = 6 per Glut1 genotype. 
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Figure 14. Lack of macrophage GLUT1
 
decreased phagocytosis in thioglycollate-elicited 
peritoneal macrophages.  
(A-B) Thioglycollate-elicited peritoneal macrophages were isolated from Glutfl/fl and Glut1MΦ-/- 
mice. Macrophages were incubated with carboxylated conjugated microspheres for 20 minutes. 
Macrophages were stained with DAPI for nuclei (blue), phalloidin for actin (green), rhodamine 
for extracellular beads (red), and after permeabilization Cy5 for intracellular beads (magenta). A 
ZEISS LSM 700 confocal microscope was used to capture representative images (20X). (C) 
Phagocytosis index was calculated by numbers of microspheres taken up by macrophages 
(magenta)/ total microspheres in field (red and magenta). (n=1 experiment).  
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Figure 15.  Working model for how decreased GLUT1-mediated glucose metabolism 
impairs phagocytosis. PFKFB3 maintains and supports regular cellular actin remodeling 
function. Reduced glucose supply decreases PFKFB3 activity, impairing macrophage phagocytic 
capacity. Deletion of GLUT1 reduces macrophage secretion of TNFα and IL-1β (data not shown, 
manuscript in preparation), which has been shown to down-regulate HIFα. HIFα increases 
PFKFB3 expression, therefore decreased HIFα reduces PFKFB3 expression, eventually leading 
to impairment of pseudopodia formation required by phagocytosis. Lastly, regular ATP/ADP and 
NADPH/NADP ratios maintains normal phagocytic capacity.  Deletion of GLUT1 decreased 
glycolysis and PPP (data not shown), which potentially down regulates ATP/ADP and 
NADPH/NADP ratios which would impair macrophages phagocytic capacity.  
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CHAPTER III- DISCUSSION 
 
Atherosclerosis is a chronic inflammatory disease and macrophages play an unparalleled 
role in its pathology but to date, the role of macrophage glucose metabolism on atherosclerosis 
remains unclear; therefore the intent of this study was to address the gap in the knowledge 
regarding the mechanistic link between macrophage glucose metabolism and the inflammatory 
response in atherogenesis by examining nutrient-responsive pathways.  In 2006, Ajay Chawla 
demonstrated that fatty acid β-oxidation is required for alternative activation of macrophages 
which is involved with inflammation resolution and wound healing (Vats et al., 2006). To study 
the role of glucose metabolism on macrophage inflammatory response, the Makowski lab has 
previously published in vitro GLUT1 gain of function (Freemerman et al., 2014) and has 
obtained preliminary data using ex vivo GLUT1 loss of function BMDM models.  These studies 
have demonstrated that glucose is a substrate that is required for activation of CAMs which 
launch the pro-inflammatory response in response to products derived from or associated with 
bacterial infections, such as lipopolysaccharide (LPS) and interferon gamma (IFNγ). Briefly, 
Freemerman et al. demonstrated that glucose transporter 1 (GLUT1) was the predominant 
glucose transporter on mouse BMDMs and mouse macrophage cell line RAW 264.7.  Over-
expression of GLUT1 on RAW cells increased their glucose uptake, glycolytic rate, and lactate 
production, and, more importantly, increased TNFα, IL-6, and MCP-1 gene expression 
(Freemerman et al., 2014). Furthermore, preliminary data showed that lack of GLUT1 
significantly decreased glucose uptake and glucose oxidation, and increased fatty acid oxidation 
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in macrophages, indicating that lack of GLUT1 shifts macrophage substrate metabolism from 
glucose to fatty acid. Simultaneously, blunted glucose metabolism mediated by deletion of 
GLUT1 significantly reduced macrophage’s capacity to mount a classical inflammatory response 
by inhibiting IL-1β expression, as well as components of the NLRP3 inflammasome including 
Caspase-3, NLRP-3, and PYCARD gene expression.  
Based on our published and previous findings, we hypothesized that macrophages will 
have reduced inflammatory activation due to lack of GLUT1 during atherogenesis, and therefore 
mice carrying macrophages with deleted GLUT1 will develop reduced atherosclerosis.  
 Based on digital histology analysis of atherosclerotic plaque in aortic root, we 
demonstrated that deletion of macrophage GLUT1, originally hypothesized to mitigate 
atherogenesis, did not affect aorta root lesion size in Ldlr-/- mice but rather increased necrotic 
core formation after  12 weeks of WD exposure. Our results demonstrated that 7 out of 8 
Glut1MΦ-/- Ldlr-/- mice but only 3 out of 8 Glut1fl/lfl Ldlr-/- mice developed necrotic cores. Further, 
we observed that Glut1MΦ-/- Ldlr-/- mice had significantly less collagen content in the aortic root 
compared to Glut1MΦ-/- Ldlr-/- mice.  Observations on systemic metabolic parameters showed that 
lack of macrophage GLUT1 did not affect body weight, fasting glucose, blood pressure, plasma 
triglyceride, or HDL cholesterol concentration. However, chimeric Glut1MΦ-/- Ldlr-/- mice 
displayed increased plasma total cholesterol and LDL cholesterol. Furthermore, preliminary 
phagocytosis assays indicated that peritoneal macrophages collected from Glut1MΦ-/- mice 
exhibited reduced phagocytic capacity compared to peritoneal macrophages collected from 
Glut1fl/fl mouse. The fact that Glut1MΦ-/- macrophages showing less phagocytic capacity 
corroborated our histologic findings that Glut1MΦ-/- Ldlr-/- mice displayed more and larger 
necrotic cores compared to Glut1fl/fl Ldlr-/- mice.  Taken together, our results indicate that 
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macrophage GLUT1 regulates systemic lipid metabolism, and more importantly, maintenance of 
atherosclerotic lesion stability may be regulated by macrophage specific glucose-dependent 
manner. This chapter will discuss potential mechanisms leading to observed phenotypes. 
Additionally, this chapter will also discuss pertinent research issues, questions, and difficulties 
that we have confronted as well as future directions. 
Effects of deletion of macrophage GLUT1 on systemic metabolic parameters 
 30% of adults in the United States are obese and nearly 75% are overweight. The high 
mortality rate tied with obesity creates a significant public health impact. Much of the mortality 
attributed to obesity is due to the metabolic disorders of insulin resistance, glucose intolerance, 
dyslipidemia, and hypertension (Odegaard & Chawla, 2011). Chronic inflammation has been 
shown to be a common etiologic mechanism for the collection of metabolic disorders called 
Metabolic Syndrome wherein macrophages play a central role in coordinating both the metabolic 
and inflammatory aspects. We and other have reported that GLUT1 is the primary glucose 
transporter in hematopoietic cells (Freemerman et al., 2014). LPS stimulation increases the rate 
of glycolysis and lactate production, and decreases glycogen storage in macrophages 
(Freemerman et al., 2014). Our first interest in the effects of deletion of macrophage’s 
predominant glucose transporter was to study systemic metabolic parameters including body 
weight, body composition, fasting glucose, blood pressure, and plasma lipids. Our data showed 
that lack of macrophage GLUT1-mediated glucose metabolism did not affect Ldlr-/- mice body 
weight, body composition, and 6 hours fasted glucose after a 12 weeks of WD exposure. The 
results were in concert with the results from another Makowski lab’s study: Glut1fl/fl and 
Glut1MΦ-/- mice were either put on 10% LFD (D12450B, Research Diet, Inc., NJ) or 45% HFD 
(D12451, Research Diet, Inc., NJ) for 23 weeks (Freemerman et al. manuscript in prep). HFD 
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increased mouse body weight significantly, but there was no significant body weight difference 
between two genotypes indicating that macrophage GLUT1 does not play a major role in 
regulating mouse body weight. CAMs in adipose tissue contribute to the onset of insulin 
resistance through secreting pro-inflammatory cytokines such as TNF-α and IL-1β. TNF-α 
stimulates serine/threonine phosphorylation of insulin receptor substrate-1 (IRS-1) mediated by 
c-Jun N-terminal kinase (JNK) (Aguirre et al., 2002). IRS-1 serine phosphorylation disrupts 
regular insulin signaling pathway and has been demonstrated to lead to insulin resistance 
(Hotamisligil, Shargill, & Spiegelman, 1993). Genetic deletion of TNF- α or its receptor greatly 
attenuates deleterious effects on insulin resistance (Odegaard & Chawla, 2011; Uysal, 
Wiesbrock, Marino, & Hotamisligil, 1997). The Makowski lab’s ex vivo preliminary data 
indicated that Glut1MΦ-/- macrophages expressed significantly less TNF-α and IL-1β compared to 
Glut1fl/fl macrophages. When Glut1fl/fl and Glut1MΦ-/- mice were made obese by a HFD, 
significantly more infiltrated macrophages were detected in Glut1MΦ-/- epididymal white adipose 
tissue than in Glut1fl/fl  mice after a 23 weeks of 45% HFD. Correspondingly, Glut1MΦ-/- mice 
expressed increased MCP-1 in adipose tissue relative to Glut1fl/fl mice. Of note, while there were 
double the number of macrophages detected in obese Glut1MΦ-/- mice, there was a lack of 
elevated TNF-a detected compared to Glut1fl/fl mice. Therefore, preliminary results indicated that 
Glut1MΦ-/- macrophages were less inflammatory but still had the capacity, with a significantly 
higher tendency, to infiltrate adipose tissue compared to Glut1fl/fl. Furthermore, flow cytometric 
analysis revealed that Glut1MΦ-/- macrophages in obese white adipose tissue failed to polarize to 
CAMs and displayed greater AAMs markers compared to Glut1fl/fl  macrophages.   
 We did not find any difference in blood pressure at the age of 16 weeks after a 6 week of 
WD exposure. Blood pressure is closely regulated by kidney, it is possible that macrophage 
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substrate metabolism does not play a major role in regulation of blood pressure through affecting 
kidney function; or 6 weeks WD may not be long enough to induce lesions which can alter blood 
pressure or macrophages themselves might play minor roles in blood pressure.   
 Glut1MΦ-/- Ldlr-/- mice displayed significantly higher plasma total and LDL cholesterol 
than Glut1fl/fl Ldlr-/-  mice at the time of sacrifice. Plasma cholesterol concentration is determined 
by the balance of cholesterol synthesis, diet cholesterol intake and cholesterol clearance. Chronic 
inflammation in liver resulting from macrophage infiltration and cytokine secretion could 
increase liver triacylglycerol and VLDL production (Popa et al., 2007). TNF-α, IL-1β, and IL-6 
increase hepatic lipogenesis through upregulating liver citrate concentration which is an 
allosteric activator of acetyl CoA carboxylase (ACC), the rate-limiting enzyme of the 
endogenous fatty acid synthesis pathway. Our preliminary data have demonstrated that GLUT1 
deletion largely reduced pro-inflammatory cytokine IL-1β secretion by BMDMs in vitro. The 
observed result that Glut1MΦ-/- Ldlr-/- mice had higher plasma total and LDL cholesterol 
compared to Glut1fl/fl Ldlr-/- mice may seem contradictory to the preliminary data. One potential 
explanation for this discrepancy is that increased macrophages infiltrating into liver due to lack 
of GLUT1 may have caused elevated total TNF-α and IL-1β in liver which in turn increases de 
novo cholesterol synthesis (Zhao et al., 2011)  Another possible interpretation is that deletion of 
GLUT1 tends to polarize macrophages to AAMs which requires the activation of PPARγ (Vats 
et al., 2006). PPARγ increases the expression of ABCA1 and ABCG1 which efflux intracellular 
cholesterol to HDL. HDL exchanges cholesterol with VLDL triacylglycerol mediated by 
cholesterol ester triglyceride transporter protein (CETP) in plasma. Taken together, we 
hypothesize that more Glut1MΦ-/- macrophages infiltrating into the liver to stimulate hepatic 
lipogenesis contributes to increased plasma cholesterol and LDL.  
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Effects of lack of glucose metabolism on atherosclerosis lesion 
Our study sought to investigate the role of macrophage GLUT1 on the pathogenesis of 
atherosclerosis through a loss-of-function strategy by studying how lack of macrophage GLUT1 
affects atherogenesis. Our lab has successfully manipulated hematopoietic macrophage 
phenotype by switching their substrate metabolism from utilizing glucose to employing fatty acid 
through deletion of its predominant glucose transporter 1 (GLUT1). As a result, macrophages 
display blunted pro-inflammatory activation due to lack of glucose metabolism. Inflammation is 
the major pathological process of atherosclerosis development. We originally hypothesized that 
deletion of GLUT1 on macrophages would decrease atherogenesis. However, after a 12 week 
WD exposure, we did not observe significant differences in lesion size in aorta sinus between 
GLUT1fl/fl Ldlr-/- and GLUT1MΦ-/- Ldlr-/- mice. Nishizawa et al. recently published an 
investigation of how over-expressed macrophage GLUT1 altered atherogenesis. They 
demonstrated that overexpression of macrophage GLUT1 did not increase lesion size (Nishizawa 
et al., 2014). Both studies intended to investigate the role of macrophage GLUT1 but utilizing 
opposite strategies: we utilized loss-of-function strategy by deletion of macrophage GLUT1 and 
they used gain-of-function method by over-expression macrophage GLUT1. Our result is 
consistent with Nishizawa’s result that macrophage GLUT1 mediated glucose metabolism does 
not affect atherosclerosis lesion size per se (Ma et al., 2012; Nishizawa et al., 2014).    
Effects of lack of glucose metabolism on necrotic cores 
 The majority of cardiovascular clinical events result from consequences of lesion rupture 
instead of lesion-caused blood vessel stenosis. The unstable atherosclerotic plaque is 
characterized by large necrotic core appearance and thinning of the fibrotic cap. Glucose is a 
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critical energy source for maintaining proper immune cell function. The glycolysis pathway is 
essential in triggering the respiratory burst and facilitating actin cytoskeleton rearrangement, 
which is associated with macrophage phagocytic capacity and therefore could potentially affect 
lesion necrotic core formation. We observed 7 out 8 Glut1MΦ-/- Ldlr-/- mice developed necrotic 
cores but only 3 out 8 Glut1fl/fl Ldlr-/- mice formed necrotic area after a 12 weeks of WD 
exposure. The result did not reach statistical significance due to relatively small sample size. 16 
mice from each genetic group were used for our study, but hearts from 8 mice from each 
genotype were used for studying lesion size. Hearts used for studying lesion size were embedded 
in Optimal Cutting Temperature (OCT) and used for ORO staining, which is a method to study 
lipid accumulation. Unfortunately, ORO can’t be used to study lesion morphology and structure, 
therefore only n=8 mice from each group were used for quantifying lesion morphology. In future 
studies, we will conduct more experiments to increase our sample size or develop an alternative 
protocol such as only staining heart sections with Masson’s trichrome.  
Macrophage phagocytosis is a process that involves cooperative interaction among 
receptors, exogenous substances, and actin filaments. Rearrangement of the actin cytoskeleton is 
essential to macrophage function and is considered to be an energy draining process (Everett, 
Barghouthi, & Speert, 1996; Venter et al., 2014). The dynamics of actin cytoskeleton remodeling 
is determined by ATP/ADP ratio, NAD (P)/NAD (P)H ratio, and intracellular pH. Glucose 
participates in three major metabolic pathways including glycolysis, glycogen synthesis, and 
Pentose Phosphate Pathway (PPP). PPP is the cell’s major source for riboses and NADPHs, 
which, respectively, are building blocks for DNA and intracellular reducing agents. Freemerman 
et al. demonstrated that over-expression of GLUT1 in RAW246.7 cells increased PPP 
metabolites. Conversely lack of GLUT1 in BMDMs decreased PPP metabolites (data not 
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shown), indicating that overexpression or deletion macrophage’s predominant glucose 
transporter GLUT1 can alter cells NADP/NADPH ratio, therefore could be one potential 
mechanism to change macrophage’s phagocytic capacity.  
Several glycolytic enzymes are associated with the actin cytoskeleton and with actin-
dependent cellular structures, such as pseudopodia, membrane ruffles, and lamellipodia (Venter 
et al., 2014). Therefore, glucose metabolism and actin-based cell dynamics are tied together. LPS 
stimulates the macrophage to become pro-inflammatory through classically activated pathway 
which induces a shift in macrophage redox potential, accompanied by increased flux through 
glycolysis as well as the PPP for NADPH production (Venter et al., 2014).  Murine peritoneal 
macrophages express GLUT1 which mediates the transport of 2-deoxyglucose, glucose, and 
mannose into the macrophage. Phagocytic capacity of peritoneal macrophages is inhibited by a 
low concentration of non-metabolizable 2-deoxyglucose indicating that an intracellular 
metabolite of glucose may trigger phagocytosis (Everett et al., 1996).  Nishizawa et al. showed 
that in BMDMs 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3) expression 
along with hexokinase-3 (HK-3) significantly increased upon LPS treatment but decreased with 
GLUT1 knocked down by siRNA.(Nishizawa et al., 2014).  Similar to macrophages, endothelial 
cells are highly glycolytic and PFKFB3 controls the formation of filopodia/lamellipodia, which 
are actin projections on the leading edge of cell; PFKFB3 silencing impairs lamellipodia 
formation (De Bock et al., 2013). Taken together, we hypothesize that Glut1MΦ-/- 
macrophages have reduced PFKFB3 activity leading to defective actin cytoskeleton 
remodeling and efferocytosis; apoptotic cell debris in atherosclerotic lesions are not 
effectively cleared by Glut1MΦ-/- macrophages therefore more and larger necrotic cores are 
evident.  
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Interestingly, we found differences in necrotic cores, but Nishizawa’s study did not 
observe difference in necrotic areas. One possible interpretation for this disparity is that 
manipulating macrophage’s metabolism into more glycolytic through overexpression of GLUT1 
increases PFKFB3 expression, which either maintains or increases macrophage’s phagocytic 
capacity. Deletion of macrophage GLUT1 inhibits the glycolysis pathway and therefore PFKFB3 
expression is suppressed which impairs the cell’s phagocytic capacity (Figure 15). Another 
explanation for the observed disparity is that in our model chimeric Ldlr-/- mice were on high 
cholesterol atherogenic diet for 12 weeks but chimeric Ldlr-/- mice in Nishizawa’s study were on 
10% low fat  diet for 22 weeks.  In summary, by utilizing either gain-of-function or loss-of-
function strategy Nishizawa et al and we observed different results of atherosclerotic necrotic 
cores which may result from different PFKFB3 enzyme activities or diet feeding paradigms.  
Consideration of Study Design  
 In order to specifically delete GLUT1 in macrophages, we crossed LysM-Cre mouse with 
Glut1fl/fl mice. Cre recombinase was inserted after the promoter for the lysozyme 2 gene. 
Knocking in Cre recombinase in the location of Lysozyme 2 gene abolishes Lysozyme 2 
expression but turns on Cre recombinase expression under the control of the endogenous 
Lysozyme2 promoter/enhance elements. Lysozyme 2 is expressed in the myeloid cell lineage 
including monocytes, mature macrophages, and granulocytes. Two LoxP sites were inserted 
respectively at intron 2 and intron 9 of the mouse Glut1 gene (Young et al., 2011). When we 
crossed LysM-Cre mice with Glut1fl/fl mice, Glut1 was successfully deleted in macrophages 
(manuscript in preparation). Since Lysozyme 2 is expressed in all cells from myeloid origin, 
neutrophil Glut1 is simultaneously deleted, we will investigate the role of lack of neutrophil 
GLUT1 on atherosclerosis in the future.  
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We employed BMT model to study the role of macrophage GLUT1 on the pathogenesis 
of atherosclerosis. BMT model has been extensively used in studying cells from hematopoietic 
origins. A lethal dose of irradiation ablates the hematopoietic system, but transplanting viable 
hematopoietic stem progenitor cells into irradiated animals that will salvage their hematopoietic 
systems by reconstitution. By day 21 after BMT, peripheral hematopoietic reconstitution of all 
cell lineage numbers may reach normal levels but many of the innate cellular effectors are yet 
not fully functional. If the donor hematopoietic stem cells fail to engraft, recipients eventually 
will succumb to infection secondary to bone marrow aplasia, anemia, or thrombocytopenia 
(Duran-Struuck & Dysko, 2009).  In our experiments, we let the recipient mice reconstitute for 4 
weeks before performing other experiment procedures. Ldlr-/- mice develop small fatty streaks on 
the aorta after 4 weeks on WD (Aslanian, Chapman, & Charo, 2005) and exhibit endothelial 
disruption and an accumulation of macrophage and foam cells at the site of atherosclerotic 
plaques after 12 weeks on a high cholesterol diet (Mehta et al., 2007). We chose our study 
endpoint at the age of 22 weeks which is after 12 weeks on WD. A glycolysis-driven metabolic 
program prompts macrophages to trigger rapid and vigorous responses toward infection, 
therefore it is possible that we might miss the dynamics of Glut1MΦ-/- driven atherosclerosis 
development after 12 weeks WD exposure. Given the unique role of glucose metabolism on 
macrophages, it might be helpful to conduct experiments to study different lengths of WD 
exposure. 
Future Studies and Implications of Our Findings  
We observed that 7 out of 8 Glut1MΦ-/- Ldlr-/- mice developed necrotic cores but only 3 
out 8 Glut1fl/fl Ldlr--/- mice formed necrotic cores after 12 weeks WD exposure. We had total 
n=16 mice in each genotype, but only used 8 mice from individual genotype for analyzing lesion 
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morphology. We observed a more than 50% increase in necrotic area (µm2) in Glut1MΦ-/- Ldlr-/- 
relative to Glut1fl/fl Ldlr-/- mice, and 87.5% of Glut1MΦ-/- Ldlr-/-  mice but only 37.5% of Glut1fl/fl 
Ldlr-/- mice developed necrotic cores. However, limited by the number of animals, necrotic core 
differences between the two study groups did not reach statistical significance. First and 
foremost, we need to increase our study power by increasing our sample size in order to detect 
significant differences in necrotic area. Next, we observed an increase in plasma total cholesterol 
and LDL cholesterol in Glut1MΦ-/- Ldlr-/- mice than Glut1fl/fl Ldlr-/- mice. Increased plasma total 
cholesterol and LDL cholesterol are secondary to either increased VLDL export from liver or 
decreased cholesterol clearance. We harvested liver when we sacrificed mice, therefore 
measuring liver triacylglycerol and cholesterol concentrations could generate evidence whether 
there is difference in the lipid accumulation in liver. Examining liver macrophage infiltration and 
subtypes would be informative as to whether there is increased macrophage infiltration in 
GLUT1MΦ-/- Ldlr-/- livers.  
Our pilot phagocytosis assay indicated that macrophages without GLUT1 have decreased 
phagocytic capacities. We need to repeat this experiment to confirm our findings. Since the 
phagocytosis assay was conducted using mouse IgG opsonized microspheres, efferocytosis 
assays wherein macrophages engulf apoptotic cell debris need to be conducted in order to 
recapitulate what happen in vivo more closely.  
In summary, this study provides evidence for the first time that macrophage GLUT1 
dependent glucose metabolism plays a critical role in maintaining atherosclerotic lesion stability. 
The results shed light on the potential mechanistic link between macrophage GLUT1 mediated 
glucose metabolism and pathogenesis of atherosclerotic. Through “metabolically reprograming” 
the inflammatory potential of macrophages via GLUT1 mediated pathways, we have 
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demonstrated that lack of macrophage GLUT1 protected mice from HFD-induced obesity. 
Macrophages are an extremely heterogeneous population of cells with the capacity for metabolic 
flexibility with important implications for both systemic and local responses. Therefore, our 
particular model warrants further investigation of the temporal and spatial control of chronic 
inflammatory disease with macrophage GLUT1 mediated glucose metabolism. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 67 
 
REFERENCES 
Aguirre, V., Werner, E. D., Giraud, J., Lee, Y. H., Shoelson, S. E., & White, M. F. (2002). 
Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the 
insulin receptor and inhibits insulin action. The Journal of Biological Chemistry, 277(2), 
1531-1537. doi:10.1074/jbc.M101521200 [doi] 
Alexander, R. W. (1995). Theodore cooper memorial lecture. hypertension and the pathogenesis 
of atherosclerosis. oxidative stress and the mediation of arterial inflammatory response: A 
new perspective. Hypertension, 25(2), 155-161.  
Altman, R. (2003). Risk factors in coronary atherosclerosis athero-inflammation: The meeting 
point. Thrombosis Journal, 1(1), 4. doi:10.1186/1477-9560-1-4 [doi] 
Aslanian, A. M., Chapman, H. A., & Charo, I. F. (2005). Transient role for CD1d-restricted 
natural killer T cells in the formation of atherosclerotic lesions. Arteriosclerosis, 
Thrombosis, and Vascular Biology, 25(3), 628-632. doi:01.ATV.0000153046.59370.13 [pii] 
Becker, L., Gharib, S. A., Irwin, A. D., Wijsman, E., Vaisar, T., Oram, J. F., & Heinecke, J. W. 
(2010). A macrophage sterol-responsive network linked to atherogenesis. Cell Metabolism, 
11(2), 125-135. doi:10.1016/j.cmet.2010.01.003 [doi] 
Bjorkbacka, H., Kunjathoor, V. V., Moore, K. J., Koehn, S., Ordija, C. M., Lee, M. A., . . . 
Freeman, M. W. (2004). Reduced atherosclerosis in MyD88-null mice links elevated serum 
cholesterol levels to activation of innate immunity signaling pathways. Nature Medicine, 
10(4), 416-421. doi:10.1038/nm1008 [doi] 
Boullier, A., Bird, D. A., Chang, M. K., Dennis, E. A., Friedman, P., Gillotre-Taylor, K., . . . 
Witztum, J. L. (2001). Scavenger receptors, oxidized LDL, and atherosclerosis. Annals of 
the New York Academy of Sciences, 947, 214-22; discussion 222-3.  
Boyle, J. J., Weissberg, P. L., & Bennett, M. R. (2003). Tumor necrosis factor-alpha promotes 
macrophage-induced vascular smooth muscle cell apoptosis by direct and autocrine 
mechanisms. Arteriosclerosis, Thrombosis, and Vascular Biology, 23(9), 1553-1558. 
doi:10.1161/01.ATV.0000086961.44581.B7 [doi] 
Chade, A. R., Lerman, A., & Lerman, L. O. (2005). Kidney in early atherosclerosis. 
Hypertension, 45(6), 1042-1049. doi:01.HYP.0000167121.14254.a0 [pii] 
Chawla, A., Nguyen, K. D., & Goh, Y. P. (2011). Macrophage-mediated inflammation in 
metabolic disease. Nature Reviews.Immunology, 11(11), 738-749. doi:10.1038/nri3071 [doi] 
Chinetti-Gbaguidi, G., Colin, S., & Staels, B. (2015). Macrophage subsets in atherosclerosis. 
Nature Reviews.Cardiology, 12(1), 10-17. doi:10.1038/nrcardio.2014.173 [doi] 
 68 
 
Chinetti-Gbaguidi, G., & Staels, B. (2011). Macrophage polarization in metabolic disorders: 
Functions and regulation. Current Opinion in Lipidology, 22(5), 365-372. 
doi:10.1097/MOL.0b013e32834a77b4 [doi] 
Coppolino, M. G., Dierckman, R., Loijens, J., Collins, R. F., Pouladi, M., Jongstra-Bilen, J., . . . 
Grinstein, S. (2002). Inhibition of phosphatidylinositol-4-phosphate 5-kinase ialpha impairs 
localized actin remodeling and suppresses phagocytosis. The Journal of Biological 
Chemistry, 277(46), 43849-43857. doi:10.1074/jbc.M209046200 [doi] 
De Bock, K., Georgiadou, M., Schoors, S., Kuchnio, A., Wong, B. W., Cantelmo, A. R., . . . 
Carmeliet, P. (2013). Role of PFKFB3-driven glycolysis in vessel sprouting. Cell, 154(3), 
651-663. doi:10.1016/j.cell.2013.06.037 [doi] 
Di Luozzo, G. (2012). http://www.aortarepair.com/anatomy.html. 
Dickhout, J. G., Basseri, S., & Austin, R. C. (2008). Macrophage function and its impact on 
atherosclerotic lesion composition, progression, and stability: The good, the bad, and the 
ugly. Arteriosclerosis, Thrombosis, and Vascular Biology, 28(8), 1413-1415. 
doi:10.1161/ATVBAHA.108.169144 [doi] 
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., . . . Latz, 
E. (2010). NLRP3 inflammasomes are required for atherogenesis and activated by 
cholesterol crystals. Nature, 464(7293), 1357-1361. doi:10.1038/nature08938 [doi] 
Duran-Struuck, R., & Dysko, R. C. (2009). Principles of bone marrow transplantation (BMT): 
Providing optimal veterinary and husbandry care to irradiated mice in BMT studies. Journal 
of the American Association for Laboratory Animal Science : JAALAS, 48(1), 11-22.  
Erbay, E., Babaev, V. R., Mayers, J. R., Makowski, L., Charles, K. N., Snitow, M. E., . . . 
Hotamisligil, G. S. (2009). Reducing endoplasmic reticulum stress through a macrophage 
lipid chaperone alleviates atherosclerosis. Nature Medicine, 15(12), 1383-1391. 
doi:10.1038/nm.2067 [doi] 
Everett, K. D., Barghouthi, S., & Speert, D. P. (1996). In vitro culture of murine peritoneal and 
alveolar macrophages modulates phagocytosis of pseudomonas aeruginosa and glucose 
transport. Journal of Leukocyte Biology, 59(4), 539-544.  
Flannagan, R. S., Jaumouille, V., & Grinstein, S. (2012). The cell biology of phagocytosis. 
Annual Review of Pathology, 7, 61-98. doi:10.1146/annurev-pathol-011811-132445 [doi] 
Freemerman, A. J., Johnson, A. R., Sacks, G. N., Milner, J. J., Kirk, E. L., Troester, M. A., . . . 
Makowski, L. (2014). Metabolic reprogramming of macrophages: Glucose transporter 1 
(GLUT1)-mediated glucose metabolism drives a proinflammatory phenotype. The Journal 
of Biological Chemistry, 289(11), 7884-7896. doi:10.1074/jbc.M113.522037 [doi] 
 69 
 
Frostegard, J. (2013). Immunity, atherosclerosis and cardiovascular disease. BMC Medicine, 11, 
117-7015-11-117. doi:10.1186/1741-7015-11-117 [doi] 
Fruchart, J. C., Nierman, M. C., Stroes, E. S., Kastelein, J. J., & Duriez, P. (2004). New risk 
factors for atherosclerosis and patient risk assessment. Circulation, 109(23 Suppl 1), III15-
9. doi:10.1161/01.CIR.0000131513.33892.5b [doi] 
Geissmann, F., Jung, S., & Littman, D. R. (2003). Blood monocytes consist of two principal 
subsets with distinct migratory properties. Immunity, 19(1), 71-82. doi:S1074761303001742 
[pii] 
Getz, G. S., & Reardon, C. A. (2012). Animal models of atherosclerosis. Arteriosclerosis, 
Thrombosis, and Vascular Biology, 32(5), 1104-1115. doi:10.1161/ATVBAHA.111.237693 
[doi] 
Grundy, S. M. (2002). Obesity, metabolic syndrome, and coronary atherosclerosis. Circulation, 
105(23), 2696-2698.  
Hess, K., Marx, N., & Lehrke Michael. (2012). Cardiovascular disease and diabetes: The 
vulnerable  patient., B4-B13. doi:http://dx.doi.org/10.1093/eurheartj/sus002 
Hopkins, P. N. (2013). Molecular biology of atherosclerosis. Physiological Reviews, 93(3), 
1317-1542. doi:10.1152/physrev.00004.2012 [doi] 
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002). SREBPs: Activators of the complete 
program of cholesterol and fatty acid synthesis in the liver. The Journal of Clinical 
Investigation, 109(9), 1125-1131. doi:10.1172/JCI15593 [doi] 
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993). Adipose expression of tumor 
necrosis factor-alpha: Direct role in obesity-linked insulin resistance. Science (New York, 
N.Y.), 259(5091), 87-91.  
Johnson, A. R., Milner, J. J., & Makowski, L. (2012). The inflammation highway: Metabolism 
accelerates inflammatory traffic in obesity. Immunological Reviews, 249(1), 218-238. 
doi:10.1111/j.1600-065X.2012.01151.x [doi] 
Kolovou, G., Anagnostopoulou, K., Mikhailidis, D. P., & Cokkinos, D. V. (2008). 
Apolipoprotein E knockout models. Current Pharmaceutical Design, 14(4), 338-351.  
Leitinger, N., & Schulman, I. G. (2013). Phenotypic polarization of macrophages in 
atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology, 33(6), 1120-1126. 
doi:10.1161/ATVBAHA.112.300173 [doi] 
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007). Obesity induces a phenotypic switch in 
adipose tissue macrophage polarization. The Journal of Clinical Investigation, 117(1), 175-
184. doi:10.1172/JCI29881 [doi] 
 70 
 
Lusis, A. J. (2000). Atherosclerosis. Nature, 407(6801), 233-241. doi:10.1038/35025203 [doi] 
Ma, Y., Wang, W., Zhang, J., Lu, Y., Wu, W., Yan, H., & Wang, Y. (2012). Hyperlipidemia and 
atherosclerotic lesion development in ldlr-deficient mice on a long-term high-fat diet. PloS 
One, 7(4), e35835. doi:10.1371/journal.pone.0035835 [doi] 
Makowski, L., Boord, J. B., Maeda, K., Babaev, V. R., Uysal, K. T., Morgan, M. A., . . . Linton, 
M. F. (2001a). Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in 
apolipoprotein E against atherosclerosis. Nature Medicine, 7(6), 699-705. 
doi:10.1038/89076 [doi] 
Makowski, L., Boord, J. B., Maeda, K., Babaev, V. R., Uysal, K. T., Morgan, M. A., . . . Linton, 
M. F. (2001b). Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in 
apolipoprotein E against atherosclerosis. Nature Medicine, 7(6), 699-705. 
doi:10.1038/89076 [doi] 
Makowski, L., Brittingham, K. C., Reynolds, J. M., Suttles, J., & Hotamisligil, G. S. (2005). The 
fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and 
inflammatory activity. macrophage expression of aP2 impacts peroxisome proliferator-
activated receptor gamma and IkappaB kinase activities. The Journal of Biological 
Chemistry, 280(13), 12888-12895. doi:M413788200 [pii] 
Mehta, J. L., Sanada, N., Hu, C. P., Chen, J., Dandapat, A., Sugawara, F., . . . Sawamura, T. 
(2007). Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high 
cholesterol diet. Circulation Research, 100(11), 1634-1642. doi:CIRCRESAHA.107.149724 
[pii] 
Moore, K. J., Sheedy, F. J., & Fisher, E. A. (2013). Macrophages in atherosclerosis: A dynamic 
balance. Nature Reviews.Immunology, 13(10), 709-721. doi:10.1038/nri3520 [doi] 
Moore, K. J., & Tabas, I. (2011). Macrophages in the pathogenesis of atherosclerosis. Cell, 
145(3), 341-355. doi:10.1016/j.cell.2011.04.005 [doi] 
Nishizawa, T., Kanter, J. E., Kramer, F., Barnhart, S., Shen, X., Vivekanandan-Giri, A., . . . 
Bornfeldt, K. E. (2014). Testing the role of myeloid cell glucose flux in inflammation and 
atherosclerosis. Cell Reports, 7(2), 356-365. doi:10.1016/j.celrep.2014.03.028 [doi] 
Odegaard, J. I., & Chawla, A. (2011). Alternative macrophage activation and metabolism. 
Annual Review of Pathology, 6, 275-297. doi:10.1146/annurev-pathol-011110-130138 [doi] 
Odegaard, J. I., Ricardo-Gonzalez, R. R., Goforth, M. H., Morel, C. R., Subramanian, V., 
Mukundan, L., . . . Chawla, A. (2007a). Macrophage-specific PPARgamma controls 
alternative activation and improves insulin resistance. Nature, 447(7148), 1116-1120. 
doi:nature05894 [pii] 
 71 
 
Odegaard, J. I., Ricardo-Gonzalez, R. R., Goforth, M. H., Morel, C. R., Subramanian, V., 
Mukundan, L., . . . Chawla, A. (2007b). Macrophage-specific PPARgamma controls 
alternative activation and improves insulin resistance. Nature, 447(7148), 1116-1120. 
doi:nature05894 [pii] 
Peled, M., & Fisher, E. A. (2014). Dynamic aspects of macrophage polarization during 
atherosclerosis progression and regression. Frontiers in Immunology, 5, 579. 
doi:10.3389/fimmu.2014.00579 [doi] 
Popa, C., Netea, M. G., van Riel, P. L., van der Meer, J. W., & Stalenhoef, A. F. (2007). The role 
of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and 
cardiovascular risk. Journal of Lipid Research, 48(4), 751-762. doi:R600021-JLR200 [pii] 
Randolph, G. J. (2014). Mechanisms that regulate macrophage burden in atherosclerosis. 
Circulation Research, 114(11), 1757-1771. doi:10.1161/CIRCRESAHA.114.301174 [doi] 
Rotllan, N., Chamorro-Jorganes, A., Araldi, E., Wanschel, A. C., Aryal, B., Aranda, J. F., . . . 
Fernandez-Hernando, C. (2015). Hematopoietic Akt2 deficiency attenuates the progression 
of atherosclerosis. FASEB Journal : Official Publication of the Federation of American 
Societies for Experimental Biology, 29(2), 597-610. doi:10.1096/fj.14-262097 [doi] 
Schrijvers, D. M., De Meyer, G. R., Herman, A. G., & Martinet, W. (2007). Phagocytosis in 
atherosclerosis: Molecular mechanisms and implications for plaque progression and 
stability. Cardiovascular Research, 73(3), 470-480. doi:S0008-6363(06)00404-4 [pii] 
Seimon, T., & Tabas, I. (2009). Mechanisms and consequences of macrophage apoptosis in 
atherosclerosis. Journal of Lipid Research, 50 Suppl, S382-7. doi:10.1194/jlr.R800032-
JLR200 [doi] 
Stary, H. C., Chandler, A. B., Dinsmore, R. E., Fuster, V., Glagov, S., Insull, W.,Jr, . . . Wissler, 
R. W. (1995). A definition of advanced types of atherosclerotic lesions and a histological 
classification of atherosclerosis. A report from the committee on vascular lesions of the 
council on arteriosclerosis, american heart association. Arteriosclerosis, Thrombosis, and 
Vascular Biology, 15(9), 1512-1531.  
Steinberg, D. (2013). In celebration of the 100th anniversary of the lipid hypothesis of 
atherosclerosis. Journal of Lipid Research, 54(11), 2946-2949. doi:10.1194/jlr.R043414 
[doi] 
Subramanian, M., Thorp, E., & Tabas, I. (2015). Identification of a non-growth factor role for 
GM-CSF in advanced atherosclerosis: Promotion of macrophage apoptosis and plaque 
necrosis through IL-23 signaling. Circulation Research, 116(2), e13-24. 
doi:10.1161/CIRCRESAHA.116.304794 [doi] 
Sundaram, S., Freemerman, A. J., Johnson, A. R., Milner, J. J., McNaughton, K. K., Galanko, J. 
A., . . . Makowski, L. (2013). Role of HGF in obesity-associated tumorigenesis: C3(1)-TAg 
 72 
 
mice as a model for human basal-like breast cancer. Breast Cancer Research and 
Treatment, 142(3), 489-503. doi:10.1007/s10549-013-2741-5 [doi] 
Swirski, F. K., Libby, P., Aikawa, E., Alcaide, P., Luscinskas, F. W., Weissleder, R., & Pittet, M. 
J. (2007). Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and 
give rise to macrophages in atheromata. The Journal of Clinical Investigation, 117(1), 195-
205. doi:10.1172/JCI29950 [doi] 
Tabas, I., Williams, K. J., & Boren, J. (2007). Subendothelial lipoprotein retention as the 
initiating process in atherosclerosis: Update and therapeutic implications. Circulation, 
116(16), 1832-1844. doi:116/16/1832 [pii] 
Uysal, K. T., Wiesbrock, S. M., Marino, M. W., & Hotamisligil, G. S. (1997). Protection from 
obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature, 389(6651), 
610-614. doi:10.1038/39335 [doi] 
Van Vre, E. A., Ait-Oufella, H., Tedgui, A., & Mallat, Z. (2012). Apoptotic cell death and 
efferocytosis in atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology, 32(4), 
887-893. doi:10.1161/ATVBAHA.111.224873 [doi] 
Vats, D., Mukundan, L., Odegaard, J. I., Zhang, L., Smith, K. L., Morel, C. R., . . . Chawla, A. 
(2006). Oxidative metabolism and PGC-1beta attenuate macrophage-mediated 
inflammation. Cell Metabolism, 4(1), 13-24. doi:S1550-4131(06)00202-6 [pii] 
Venter, G., Oerlemans, F. T., Wijers, M., Willemse, M., Fransen, J. A., & Wieringa, B. (2014). 
Glucose controls morphodynamics of LPS-stimulated macrophages. PloS One, 9(5), 
e96786. doi:10.1371/journal.pone.0096786 [doi] 
Virmani, R., Burke, A. P., Farb, A., & Kolodgie, F. D. (2002). Pathology of the unstable plaque. 
Progress in Cardiovascular Diseases, 44(5), 349-356. doi:S0033062002500116 [pii] 
Wassink, A. M., Van Der Graaf, Y., Soedamah-Muthu, S. S., Spiering, W., Visseren, F. L., & 
Smart Study Group. (2008). Metabolic syndrome and incidence of type 2 diabetes in 
patients with manifest vascular disease. Diabetes & Vascular Disease Research : Official 
Journal of the International Society of Diabetes and Vascular Disease, 5(2), 114-122. 
doi:10.3132/dvdr.2008.019 [doi] 
Young, C. D., Lewis, A. S., Rudolph, M. C., Ruehle, M. D., Jackman, M. R., Yun, U. J., . . . 
Anderson, S. M. (2011). Modulation of glucose transporter 1 (GLUT1) expression levels 
alters mouse mammary tumor cell growth in vitro and in vivo. PloS One, 6(8), e23205. 
doi:10.1371/journal.pone.0023205 [doi] 
Zhang, X., Goncalves, R., & Mosser, D. M. (2008). The isolation and characterization of murine 
macrophages. Current Protocols in Immunology / Edited by John E.Coligan ...[Et Al.], 
Chapter 14, Unit 14.1. doi:10.1002/0471142735.im1401s83 [doi] 
 73 
 
Zhao, L., Chen, Y., Tang, R., Chen, Y., Li, Q., Gong, J., . . . Ruan, X. Z. (2011). Inflammatory 
stress exacerbates hepatic cholesterol accumulation via increasing cholesterol uptake and de 
novo synthesis. Journal of Gastroenterology and Hepatology, 26(5), 875-883. 
doi:10.1111/j.1440-1746.2010.06560.x [doi] 
Zhou, R. H., Vendrov, A. E., Tchivilev, I., Niu, X. L., Molnar, K. C., Rojas, M., . . . Runge, M. 
S. (2012). Mitochondrial oxidative stress in aortic stiffening with age: The role of smooth 
muscle cell function. Arteriosclerosis, Thrombosis, and Vascular Biology, 32(3), 745-755. 
doi:10.1161/ATVBAHA.111.243121 [doi] 
  
